bcwy personal page - To The Moon

bcwy

No personal profile

0Follow

1Followers

0Topic

0Badge

2021-06-18

Ford looks good to buy

Old car makers are the hot new trade: Morning Brief

2021-06-18

Apple will dip all the way

Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say

2021-06-18

Meme stocks

With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today

2021-06-18

This is so sad

Orphazyme shares tumbled more than 60% in pre-market trading

2021-06-18

Shell out more money

ChargePoint’s Network Effects Will Make It the Next ‘Shell’

2021-06-17

How do we ultimately say who "deserves" it.

Why GEO Group Is Soaring 11% This Morning

2021-06-18

Wow so many comments here

Facebook launches ads globally for Instagram Reels

2021-06-18

Uh oh, maybe business will fold soon

AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand

2021-06-18

Wow who would've guessed

Singapore slows the pace of reopening as Covid cases haven't declined significantly

2021-06-18

Great job

Google's cloud taps AMD for new service as chip wars heat up

2021-06-16

Great!

It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks

2021-06-18

Uh oh orphazyme

2021-06-18

Ok here we go

At Home Group accepts Hellman & Friedman's raised offer

2021-06-18

They will always win

HK police charges two Apple Daily execs with collusion with foreign country

2021-06-18

Post here

2021-06-18

Apple try harder

Apple Struggles in Push to Make Healthcare Its Greatest Legacy

2021-06-18

China big brother

China's liaison office in Hong Kong backs 'just action' on Apple Daily

2021-06-18

Buy the dip!

US STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance

2021-06-18

A lot of potential

Fisker Jumps on EV-Production Pact With Magna International

2021-06-18

Yeah right

Low dosage may be behind low efficacy of CureVac vaccine: Study leader

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3582871469502818,"uuid":"3582871469502818","gmtCreate":1619778373061,"gmtModify":1619778373061,"name":"bcwy","pinyin":"bcwy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":0,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":166644647,"gmtCreate":1624008474089,"gmtModify":1703826433205,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Shell out more money","listText":"Shell out more money","text":"Shell out more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166644647","repostId":"1181667218","repostType":4,"repost":{"id":"1181667218","pubTimestamp":1624008124,"share":"https://ttm.financial/m/news/1181667218?lang=&edition=fundamental","pubTime":"2021-06-18 17:22","market":"us","language":"en","title":"ChargePoint’s Network Effects Will Make It the Next ‘Shell’","url":"https://stock-news.laohu8.com/highlight/detail?id=1181667218","media":"investorplace","summary":"ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May a","content":"<p><b>ChargePoint</b>&nbsp;(NYSE:<b><u>CHPT</u></b>) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed420b8993199e014fc4d87c875c9dd5\" tg-width=\"300\" tg-height=\"169\"><span>Source: YuniqueB / Shutterstock.com</span></p>\n<p>The catalyst? There are a few of them —</p>\n<ul>\n <li>Recharged growth trade on lower bond yields</li>\n <li>Reinvigorated optimism about EVs and the charging network buildout</li>\n <li>New, rather impressive products from ChargePoint</li>\n</ul>\n<p>This will all last. EVs will take over the world, charging stations will replace gas pumps and ChargePoint will be the biggest charging company in the world when all is said and done.</p>\n<p>Here’s why.</p>\n<p>ChargePoint is North America’s largest operator of electric vehicle charging stations. It should be able to leverage their early entry into the market as well as its size. Thanks to network effects, it could turn into the EV version of<b>Shell</b>(NYSE:<b><u>RDS-A</u></b>, NYSE:<b><u>RDS-B</u></b>) or<b>Exxon</b>(NYSE:<b><u>XOM</u></b>) by 2030.</p>\n<p>On the surface, this company looks like all other EV charging companies.</p>\n<p>ChargePoint operate on the standard hardware-plus-software model — selling both physical EV charging ports and end-to-end software platforms to manage them. Its assortment of chargers includes L2 chargers and a smattering of DC fast chargers. And it costs money, around $2 to $5, to use these chargers.</p>\n<p>Basically, ChargePoint is doing what everyone else is doing, but there’s so much more to it than that …</p>\n<p>CHPT Stock: Network Effects Set ChargePoint Apart</p>\n<p>Where ChargePoint shines is in its unparalleled size and dominance in the EV charging station market.</p>\n<p>It’s seven times larger than its nearest competitor, with over 100,000 charging ports and 73% of L2 EV charging stations.</p>\n<p>Its size is especially significant because of network effects.</p>\n<p>Of ChargePoint’s commercial clients, more than 60% of&nbsp;<b>Fortune 500</b>&nbsp;companies employ ChargePoint charging stations at their corporate offices. If companies such as<b>Facebook</b>(NASDAQ:<b><u>FB</u></b>),<b>Netflix</b>(NASDAQ:<b><u>NFLX</u></b>),<b>Salesforce</b>(NYSE:<b><u>CRM</u></b>),<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and<b>Adobe</b>(NASDAQ:<b><u>ADBE</u></b>) already utilize ChargePoint chargers — which shows other companies who to turn to when they want to install their own EV charging stations — ChargePoint should be able to leverage this array of existing customers to win more and more big-name contracts.</p>\n<p>ChargePoint is on its way to dominating the commercial workplace vertical of the EV market for the near- to long-term future.</p>\n<p>From a consumer-facing perspective, ChargePoint is also setting itself up for future success.</p>\n<p>The company hasteamed up with auto makerslike Mercedes-owner&nbsp;<b>Daimler AG</b>(OTCMKTS:<b><u>DMLRY</u></b>) and<b>BMW</b>(OTC:<b><u>BMWYY</u></b>) tointegrate the locations of its charging stationsinto in-car navigation systems.</p>\n<p>ChargePoint also offers a popular app that enables drivers to locate its charging stations, see if they’re currently in-use or not and check prices. The app keeps ChargePoint on consumers’ minds, which will help the company dominate the at-home, residential EV-charging market.</p>\n<p>Again, it all comes down to ChargePoint’s unmatched network effects.</p>\n<p>Which is why I believe that, as EVs gradually replace gas cars, ChargePoint has the potential to replace Shell as the leading operator of “refueling” stations.</p>\n<p>Naturally, that would mean huge upside potential for CHPT stock.</p>\n<p>Which is why CHPT is one of my top picks in EV charging. And long-term, you can bet that CHPT stock will score investors massive returns.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ChargePoint’s Network Effects Will Make It the Next ‘Shell’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChargePoint’s Network Effects Will Make It the Next ‘Shell’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.\nSource: YuniqueB / Shutterstock.com\nThe ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc."},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181667218","content_text":"ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.\nSource: YuniqueB / Shutterstock.com\nThe catalyst? There are a few of them —\n\nRecharged growth trade on lower bond yields\nReinvigorated optimism about EVs and the charging network buildout\nNew, rather impressive products from ChargePoint\n\nThis will all last. EVs will take over the world, charging stations will replace gas pumps and ChargePoint will be the biggest charging company in the world when all is said and done.\nHere’s why.\nChargePoint is North America’s largest operator of electric vehicle charging stations. It should be able to leverage their early entry into the market as well as its size. Thanks to network effects, it could turn into the EV version ofShell(NYSE:RDS-A, NYSE:RDS-B) orExxon(NYSE:XOM) by 2030.\nOn the surface, this company looks like all other EV charging companies.\nChargePoint operate on the standard hardware-plus-software model — selling both physical EV charging ports and end-to-end software platforms to manage them. Its assortment of chargers includes L2 chargers and a smattering of DC fast chargers. And it costs money, around $2 to $5, to use these chargers.\nBasically, ChargePoint is doing what everyone else is doing, but there’s so much more to it than that …\nCHPT Stock: Network Effects Set ChargePoint Apart\nWhere ChargePoint shines is in its unparalleled size and dominance in the EV charging station market.\nIt’s seven times larger than its nearest competitor, with over 100,000 charging ports and 73% of L2 EV charging stations.\nIts size is especially significant because of network effects.\nOf ChargePoint’s commercial clients, more than 60% of Fortune 500 companies employ ChargePoint charging stations at their corporate offices. If companies such asFacebook(NASDAQ:FB),Netflix(NASDAQ:NFLX),Salesforce(NYSE:CRM),Microsoft(NASDAQ:MSFT) andAdobe(NASDAQ:ADBE) already utilize ChargePoint chargers — which shows other companies who to turn to when they want to install their own EV charging stations — ChargePoint should be able to leverage this array of existing customers to win more and more big-name contracts.\nChargePoint is on its way to dominating the commercial workplace vertical of the EV market for the near- to long-term future.\nFrom a consumer-facing perspective, ChargePoint is also setting itself up for future success.\nThe company hasteamed up with auto makerslike Mercedes-owner Daimler AG(OTCMKTS:DMLRY) andBMW(OTC:BMWYY) tointegrate the locations of its charging stationsinto in-car navigation systems.\nChargePoint also offers a popular app that enables drivers to locate its charging stations, see if they’re currently in-use or not and check prices. The app keeps ChargePoint on consumers’ minds, which will help the company dominate the at-home, residential EV-charging market.\nAgain, it all comes down to ChargePoint’s unmatched network effects.\nWhich is why I believe that, as EVs gradually replace gas cars, ChargePoint has the potential to replace Shell as the leading operator of “refueling” stations.\nNaturally, that would mean huge upside potential for CHPT stock.\nWhich is why CHPT is one of my top picks in EV charging. And long-term, you can bet that CHPT stock will score investors massive returns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166642240,"gmtCreate":1624008407380,"gmtModify":1703826430938,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh, maybe business will fold soon","listText":"Uh oh, maybe business will fold soon","text":"Uh oh, maybe business will fold soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166642240","repostId":"1176081814","repostType":4,"repost":{"id":"1176081814","pubTimestamp":1624002595,"share":"https://ttm.financial/m/news/1176081814?lang=&edition=fundamental","pubTime":"2021-06-18 15:49","market":"us","language":"en","title":"AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=1176081814","media":"bloomberg","summary":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery tar","content":"<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.</p>\n<p>Thailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.</p>\n<p>Shipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.</p>\n<p>The situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.</p>\n<p>AstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.</p>\n<p>The Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.</p>\n<p>AstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.</p>\n<p>Seeking Alternatives</p>\n<p>The Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.</p>\n<p>While not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.</p>\n<p>Now, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.</p>\n<p>Thailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.</p>\n<p>The country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson &amp; Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.</p>\n<p>New to Vaccine-making</p>\n<p>AstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.</p>\n<p>But the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.</p>\n<p>“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”</p>\n<p>AstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.</p>\n<p>The company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.</p>\n<p>It’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.</p>\n<p>In February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.</p>\n<p>Royal Links</p>\n<p>Complicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.</p>\n<p>In January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.</p>\n<p>When former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.</p>\n<p>Prime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.</p>\n<p>One Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.</p>\n<p>“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia><strong>bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176081814","content_text":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.\nThailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.\nShipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.\nThe situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.\nAstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.\nThe Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.\nAstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.\nSeeking Alternatives\nThe Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.\nWhile not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.\nNow, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.\nThailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.\nThe country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson & Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.\nNew to Vaccine-making\nAstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.\nBut the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.\n“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”\nAstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.\nThe company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.\nIt’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.\nIn February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.\nRoyal Links\nComplicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.\nIn January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.\nWhen former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.\nPrime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.\nOne Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.\n“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166646213,"gmtCreate":1624008372332,"gmtModify":1703826429326,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh orphazyme","listText":"Uh oh orphazyme","text":"Uh oh orphazyme","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166646213","isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648869,"gmtCreate":1624008279651,"gmtModify":1703826427502,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Ok here we go","listText":"Ok here we go","text":"Ok here we go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648869","repostId":"2143926717","repostType":2,"repost":{"id":"2143926717","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623854867,"share":"https://ttm.financial/m/news/2143926717?lang=&edition=fundamental","pubTime":"2021-06-16 22:47","market":"us","language":"en","title":"At Home Group accepts Hellman & Friedman's raised offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2143926717","media":"Reuters","summary":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equ","content":"<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>At Home Group accepts Hellman & Friedman's raised offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAt Home Group accepts Hellman & Friedman's raised offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOME":"At Home Group Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143926717","content_text":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman & Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.\nPlano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.\nHonest Capital said in May, in a letter to At Home, the initial offer from Hellman & Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.\nAt Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.\n\"This price increase represents our best and final offer,\" Hellman & Friedman Partner Erik Ragatz said in a statement on Wednesday.\nH&F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.\nHonest Capital could not be immediately reached for a comment, and CAS did not immediately respond.","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648341,"gmtCreate":1624008259483,"gmtModify":1703826427179,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Wow who would've guessed","listText":"Wow who would've guessed","text":"Wow who would've guessed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648341","repostId":"1113093847","repostType":4,"repost":{"id":"1113093847","pubTimestamp":1624001134,"share":"https://ttm.financial/m/news/1113093847?lang=&edition=fundamental","pubTime":"2021-06-18 15:25","market":"sg","language":"en","title":"Singapore slows the pace of reopening as Covid cases haven't declined significantly","url":"https://stock-news.laohu8.com/highlight/detail?id=1113093847","media":"cnbc","summary":"SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next ","content":"<div>\n<p>SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore slows the pace of reopening as Covid cases haven't declined significantly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore slows the pace of reopening as Covid cases haven't declined significantly\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1113093847","content_text":"SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined significantly.\nThe government startedrelaxing some measuresthis week, including increasing the limits on social gatherings and event attendees.\nIt said that starting Monday, \"higher-risk activities\" such as dining in and indoor mask-off sports and exercises will be allowed to resume in groups of two people — instead of five people as previously announced.\nBarring another super-spreader event or a big cluster of infections, the government will allow those activities for groups of up to five around mid-July.\nSingapore has to be cautious in resuming activities deemed to be of higher risks due to the more transmissible delta variant first detected in India, Health Minister Ong Ye Kung told reporters at a briefing.\nOng said that with a phased reopening, \"we buy time to get more people vaccinated, so the imperative now is to boost vaccinations.\"\nSingapore hasone of the fastest vaccination roll-outsin Asia-Pacific. Around 2.7 million people — or roughly 47% of the population — have received at least the first dose of Covid vaccine as of Monday,latest data by the health ministryshowed.\nThe country had largely controlled the spread of Covid until a flare-up in locally transmitted cases in end-April.Many of the recent cases were caused by the delta variant. The rise in cases forced the government totighten social-distancing measurestwice last month.\nDaily reported casesin the local community fell to single-digit levels for most of last week, but have stayed above 10 cases per day since Sunday as a major cluster of infections emerged around a wet market in southern Singapore.\nOverall, the Southeast Asian country has reported 34 deaths and more than 62,300 confirmed cases since the beginning of 2020 as of Thursday, health ministry data showed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641587,"gmtCreate":1624008226649,"gmtModify":1703826426373,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"This is so sad","listText":"This is so sad","text":"This is so sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641587","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641861,"gmtCreate":1624008197353,"gmtModify":1703826426041,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Ford looks good to buy&nbsp;","listText":"Ford looks good to buy&nbsp;","text":"Ford looks good to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641861","repostId":"2144172072","repostType":4,"repost":{"id":"2144172072","pubTimestamp":1624007350,"share":"https://ttm.financial/m/news/2144172072?lang=&edition=fundamental","pubTime":"2021-06-18 17:09","market":"us","language":"en","title":"Old car makers are the hot new trade: Morning Brief","url":"https://stock-news.laohu8.com/highlight/detail?id=2144172072","media":"Yahoo Finance","summary":"The past is outperforming the future this year.\nWe're less than a week out from the halfway point of","content":"<p>The past is outperforming the future this year.</p>\n<p>We're less than a week out from the halfway point of 2021.</p>\n<p>And <a href=\"https://laohu8.com/S/AONE\">one</a> of the big real economy stories this year has been the explosion in demand for cars. This has pushed up prices, particularly for used cars.</p>\n<p>And while most used cars, and those on the road today, are running on internal combustion engines (ICE), the industry agrees that electric vehicles (EVs) are the future. For the last decade, the best way to play that trend has been via Tesla (TSLA). Shareholders in that particular trade have been rewarded handsomely: since June 2011, the car maker's shares are up over 10,000%.</p>\n<p>This year, however, investors have been betting that the industry's old guard can make their businesses work better in an electrified future.</p>\n<p>Through Thursday's close, shares of Ford (F) and General Motors (GM) were both up more than 40%, outpacing both the broader market and all of the market's buzziest names in the EV space.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b210f3a56c6cba72ed1fbbf47bd815c\" tg-width=\"1230\" tg-height=\"498\" referrerpolicy=\"no-referrer\"><span>Ford and GM have been the leading auto stocks in 2021 as investors bet they can benefit in a growing economy and see returns from big investments in electric cars. (Source: Yahoo Finance)</span></p>\n<p>At an industry conference on Thursday, Ford CEO Jim Farley said the company's second quarter earnings were likely to come in better than expected. Earlier this week, GM announced that it would increase its investment in electric vehicles to $35 billion from $27 billion through 2025.</p>\n<p>And it was only a few weeks back that Ford announced its own ambitious plans to electrify more of its fleet, unveiling an electric F-150, its best-selling ICE vehicle, while unveiling plans to invest $30 billion in electric vehicle development over the next five years.</p>\n<p>This year's rally in shares of GM and Ford also remind us (in yet another way) how different this recovery has been from what we endured after the financial crisis.</p>\n<p>GM and Chrysler went bankrupt during the 2008-09 recession; Ford just barely staved off that fate. This time around, these companies are parlaying a surge in consumer demand into increased investments in trying to keep up with the Teslas of the world.</p>\n<p>These announcements out of Ford and GM also come as upstart competitors like Nikola (NKLA) and Lordstown Motors (RIDE) struggle to accurately communicate with investors. Nikola shares, which fell over 50% in 2020, were up about 11% this year through Thursday's close, while Lordstown's stock has been just about cut in half this year. Both Nikola and Lordstown replaced their chief executives after bold pronouncements about orders and capabilities for their vehicles didn't check out.</p>\n<p>Elon Musk's iconoclastic style at Tesla is much imitated but never duplicated by companies hoping to position themselves as the \"next Tesla.\" Tesla's Technoking really is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of one.</p>\n<p>In the years before the pandemic, Tesla's rise and the industry's electrified future pressured shares of Ford, GM, and other automakers. From the time GM emerged from bankruptcy in the fall of 2010, shares of both GM and Ford were trounced by the overall market. This year's gain does not erase that underperformance. And the lead the traditional auto industry has staked on Tesla becoming the leading electric vehicle brand will be hard to overcome.</p>\n<p>But today, what investors seem to see in Ford and GM is at least a chance. A chance to benefit from the post-pandemic economic expansion. And a chance at remaining a major player in the electrified auto market of tomorrow.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Old car makers are the hot new trade: Morning Brief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOld car makers are the hot new trade: Morning Brief\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The past is outperforming the future this year.\nWe're less than a week out from the halfway point of 2021.\nAnd one of the big real economy stories this year has been the explosion in demand for cars. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KNSL":"Kinsale Capital Group Inc.","F":"福特汽车","GM":"通用汽车","NKLA":"Nikola Corporation","TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2144172072","content_text":"The past is outperforming the future this year.\nWe're less than a week out from the halfway point of 2021.\nAnd one of the big real economy stories this year has been the explosion in demand for cars. This has pushed up prices, particularly for used cars.\nAnd while most used cars, and those on the road today, are running on internal combustion engines (ICE), the industry agrees that electric vehicles (EVs) are the future. For the last decade, the best way to play that trend has been via Tesla (TSLA). Shareholders in that particular trade have been rewarded handsomely: since June 2011, the car maker's shares are up over 10,000%.\nThis year, however, investors have been betting that the industry's old guard can make their businesses work better in an electrified future.\nThrough Thursday's close, shares of Ford (F) and General Motors (GM) were both up more than 40%, outpacing both the broader market and all of the market's buzziest names in the EV space.\nFord and GM have been the leading auto stocks in 2021 as investors bet they can benefit in a growing economy and see returns from big investments in electric cars. (Source: Yahoo Finance)\nAt an industry conference on Thursday, Ford CEO Jim Farley said the company's second quarter earnings were likely to come in better than expected. Earlier this week, GM announced that it would increase its investment in electric vehicles to $35 billion from $27 billion through 2025.\nAnd it was only a few weeks back that Ford announced its own ambitious plans to electrify more of its fleet, unveiling an electric F-150, its best-selling ICE vehicle, while unveiling plans to invest $30 billion in electric vehicle development over the next five years.\nThis year's rally in shares of GM and Ford also remind us (in yet another way) how different this recovery has been from what we endured after the financial crisis.\nGM and Chrysler went bankrupt during the 2008-09 recession; Ford just barely staved off that fate. This time around, these companies are parlaying a surge in consumer demand into increased investments in trying to keep up with the Teslas of the world.\nThese announcements out of Ford and GM also come as upstart competitors like Nikola (NKLA) and Lordstown Motors (RIDE) struggle to accurately communicate with investors. Nikola shares, which fell over 50% in 2020, were up about 11% this year through Thursday's close, while Lordstown's stock has been just about cut in half this year. Both Nikola and Lordstown replaced their chief executives after bold pronouncements about orders and capabilities for their vehicles didn't check out.\nElon Musk's iconoclastic style at Tesla is much imitated but never duplicated by companies hoping to position themselves as the \"next Tesla.\" Tesla's Technoking really is one of one.\nIn the years before the pandemic, Tesla's rise and the industry's electrified future pressured shares of Ford, GM, and other automakers. From the time GM emerged from bankruptcy in the fall of 2010, shares of both GM and Ford were trounced by the overall market. This year's gain does not erase that underperformance. And the lead the traditional auto industry has staked on Tesla becoming the leading electric vehicle brand will be hard to overcome.\nBut today, what investors seem to see in Ford and GM is at least a chance. A chance to benefit from the post-pandemic economic expansion. And a chance at remaining a major player in the electrified auto market of tomorrow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641940,"gmtCreate":1624008161080,"gmtModify":1703826425716,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"They will always win","listText":"They will always win","text":"They will always win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166641940","repostId":"2144861727","repostType":2,"repost":{"id":"2144861727","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624001354,"share":"https://ttm.financial/m/news/2144861727?lang=&edition=fundamental","pubTime":"2021-06-18 15:29","market":"hk","language":"en","title":"HK police charges two Apple Daily execs with collusion with foreign country","url":"https://stock-news.laohu8.com/highlight/detail?id=2144861727","media":"Reuters","summary":"HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executi","content":"<html><body><p>HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.</p><p>   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung.</p><p> (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)</p><p>((marius.zaharia@thomsonreuters.com; +852 2843 6358;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK police charges two Apple Daily execs with collusion with foreign country</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK police charges two Apple Daily execs with collusion with foreign country\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 15:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.</p><p>   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung.</p><p> (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)</p><p>((marius.zaharia@thomsonreuters.com; +852 2843 6358;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03086":"华夏纳指","09086":"华夏纳指-U","AAPL":"苹果"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144861727","content_text":"HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung. (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)((marius.zaharia@thomsonreuters.com; +852 2843 6358;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168358986,"gmtCreate":1623953223445,"gmtModify":1703824605541,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Post here","listText":"Post here","text":"Post here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168358986","isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351480,"gmtCreate":1623953188340,"gmtModify":1703824605213,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Apple try harder","listText":"Apple try harder","text":"Apple try harder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351480","repostId":"1139981231","repostType":2,"repost":{"id":"1139981231","pubTimestamp":1623910261,"share":"https://ttm.financial/m/news/1139981231?lang=&edition=fundamental","pubTime":"2021-06-17 14:11","market":"us","language":"en","title":"Apple Struggles in Push to Make Healthcare Its Greatest Legacy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139981231","media":"The Wall Street Journal","summary":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leade","content":"<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cdcc89ff3fd1e1d8ec3f02f3aaf52457\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Under the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.</span></p>\n<p>Apple&nbsp;Inc.&nbsp;Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.</p>\n<p>Apple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.</p>\n<p>Today those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.</p>\n<p>The new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.</p>\n<p>An Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as&nbsp;heart-rate notifications&nbsp;in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.</p>\n<p>“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.</p>\n<p>Looking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com&nbsp;Inc.’s&nbsp;high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch&nbsp;virtual care across 50 states.</p>\n<p>Under Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.</p>\n<p>Apple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.</p>\n<p>One of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.</p>\n<p>Apple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/837161c8fc0a7b93c5c67936fe293453\" tg-width=\"1260\" tg-height=\"840\"><span>Apple Chief Operating Officer Jeff Williams oversees its health unit.</span></p>\n<p>The team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.</p>\n<p>If Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.</p>\n<p>To start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.</p>\n<p>The effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.</p>\n<p>Dr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.</p>\n<p>Those issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.</p>\n<p>Apple’s spokesman said such criticisms are inaccurate.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/01a35a283d15f6de16455cae846a617b\" tg-width=\"1260\" tg-height=\"840\"><span>Dr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.</span></p>\n<p>Employees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.</p>\n<p>Apple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.</p>\n<p>The spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.</p>\n<p>Mr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.</p>\n<p>In addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.</p>\n<p>A recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.</p>\n<p>HealthHabit&nbsp;offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.</p>\n<p>Half the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.</p>\n<p>Data supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.</p>\n<p>During a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.</p>\n<p>In the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.</p>\n<p>Rival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.</p>\n<p>The Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Struggles in Push to Make Healthcare Its Greatest Legacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Struggles in Push to Make Healthcare Its Greatest Legacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 ...</p>\n\n<a href=\"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139981231","content_text":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.\nApple Inc. Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.\nApple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.\nToday those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.\nThe new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.\nAn Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as heart-rate notifications in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.\n“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.\nLooking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com Inc.’s high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch virtual care across 50 states.\nUnder Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.\nApple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.\nOne of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.\nApple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.\nApple Chief Operating Officer Jeff Williams oversees its health unit.\nThe team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.\nIf Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.\nTo start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.\nThe effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.\nDr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.\nThose issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.\nApple’s spokesman said such criticisms are inaccurate.\nDr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.\nEmployees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.\nApple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.\nThe spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.\nMr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.\nIn addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.\nA recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.\nHealthHabit offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.\nHalf the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.\nData supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.\nDuring a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.\nIn the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.\nRival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.\nThe Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.","news_type":1},"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351110,"gmtCreate":1623953150130,"gmtModify":1703824604234,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"China big brother","listText":"China big brother","text":"China big brother","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351110","repostId":"2144714222","repostType":2,"repost":{"id":"2144714222","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623907357,"share":"https://ttm.financial/m/news/2144714222?lang=&edition=fundamental","pubTime":"2021-06-17 13:22","market":"sh","language":"en","title":"China's liaison office in Hong Kong backs 'just action' on Apple Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2144714222","media":"Reuters","summary":"BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported w","content":"<html><body><p>BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.</p><p>   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement.</p><p> (Reporting by Tony Munroe; Editing by Clarence Fernandez)</p><p>((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's liaison office in Hong Kong backs 'just action' on Apple Daily</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's liaison office in Hong Kong backs 'just action' on Apple Daily\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-17 13:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.</p><p>   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement.</p><p> (Reporting by Tony Munroe; Editing by Clarence Fernandez)</p><p>((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","09086":"华夏纳指-U","03086":"华夏纳指"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144714222","content_text":"BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement. (Reporting by Tony Munroe; Editing by Clarence Fernandez)((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351085,"gmtCreate":1623953132847,"gmtModify":1703824603910,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Apple will dip all the way","listText":"Apple will dip all the way","text":"Apple will dip all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/168351085","repostId":"2144745081","repostType":2,"repost":{"id":"2144745081","pubTimestamp":1623999815,"share":"https://ttm.financial/m/news/2144745081?lang=&edition=fundamental","pubTime":"2021-06-18 15:03","market":"us","language":"en","title":"Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say","url":"https://stock-news.laohu8.com/highlight/detail?id=2144745081","media":"MarketWatch","summary":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indicatio","content":"<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.</p>\n<p>\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.</p>\n<p>Fraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.</p>\n<p>Companies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.</p>\n<p>According to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.</p>\n<p>\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.</p>\n<p>\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1aca07448aa8168cf9edc9e49d933435\" tg-width=\"1260\" tg-height=\"672\" referrerpolicy=\"no-referrer\"><span>CHART VIA BERNSTEIN RESEARCH.</span></p>\n<p>There are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, and Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, as well as other technology companies like videogame developer Electronic Arts <a href=\"https://laohu8.com/S/EA\">$(EA)$</a> and semiconductor groups Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>, and Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>.</p>\n<p>Telecom giants AT&amp;T <a href=\"https://laohu8.com/S/T\">$(T)$</a> and Verizon <a href=\"https://laohu8.com/S/VZ\">$(VZ)$</a> are also on the list, as are retailers and consumer-products groups such as Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, Target <a href=\"https://laohu8.com/S/TGT\">$(TGT)$</a>, McDonalds <a href=\"https://laohu8.com/S/MCD\">$(MCD)$</a>, Starbucks <a href=\"https://laohu8.com/S/SBUX\">$(SBUX)$</a>, Nike <a href=\"https://laohu8.com/S/NKE\">$(NKE)$</a>, Kraft Heinz <a href=\"https://laohu8.com/S/KHC\">$(KHC)$</a>, Estée Lauder <a href=\"https://laohu8.com/S/EL\">$(EL)$</a>, and Coca-Cola <a href=\"https://laohu8.com/S/KO\">$(KO)$</a>.</p>\n<p>Health and biotechnology stocks like Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, Gilead Sciences <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a>, Regeneron <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a>, and Biogen <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> also make the cut, as do railroad operators Kansas City Southern <a href=\"https://laohu8.com/S/KSU\">$(KSU)$</a> and Union Pacific <a href=\"https://laohu8.com/S/UNP\">$(UNP)$</a>. Defense companies Lockheed Martin <a href=\"https://laohu8.com/S/LMT\">$(LMT)$</a>, Northrop Grumman <a href=\"https://laohu8.com/S/NOC\">$(NOC)$</a>, and Raytheon Technologies <a href=\"https://laohu8.com/S/RTX\">$(RTX)$</a> also qualify.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLooking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert...</p>\n\n<a href=\"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","RTX":"雷神技术公司","GILD":"吉利德科学","EA":"艺电","TGT":"塔吉特","NKE":"耐克","VZ":"威瑞森","HD":"家得宝","REGN":"再生元制药公司","AMZN":"亚马逊","AAPL":"苹果","KO":"可口可乐","LMT":"洛克希德马丁","GOOGL":"谷歌A","GOOG":"谷歌","SBUX":"星巴克","KHC":"卡夫亨氏","NOC":"诺斯罗普格鲁曼","MCD":"麦当劳","KSU":"堪萨斯南方铁路","UNP":"联合太平洋","EL":"雅诗兰黛","NVDA":"英伟达","PFE":"辉瑞","TXN":"德州仪器","QCOM":"高通","MSFT":"微软"},"source_url":"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144745081","content_text":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.\n\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.\nFraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.\nCompanies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.\nAccording to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.\n\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.\n\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.\nCHART VIA BERNSTEIN RESEARCH.\nThere are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple $(AAPL)$, Alphabet $(GOOGL)$(GOOGL), Amazon $(AMZN)$, and Microsoft $(MSFT)$, as well as other technology companies like videogame developer Electronic Arts $(EA)$ and semiconductor groups Nvidia $(NVDA)$, Texas Instruments $(TXN)$, and Qualcomm $(QCOM)$.\nTelecom giants AT&T $(T)$ and Verizon $(VZ)$ are also on the list, as are retailers and consumer-products groups such as Home Depot $(HD)$, Target $(TGT)$, McDonalds $(MCD)$, Starbucks $(SBUX)$, Nike $(NKE)$, Kraft Heinz $(KHC)$, Estée Lauder $(EL)$, and Coca-Cola $(KO)$.\nHealth and biotechnology stocks like Johnson & Johnson $(JNJ)$, Pfizer $(PFE)$, Gilead Sciences $(GILD)$, Regeneron $(REGN)$, and Biogen $(BIIB)$ also make the cut, as do railroad operators Kansas City Southern $(KSU)$ and Union Pacific $(UNP)$. Defense companies Lockheed Martin $(LMT)$, Northrop Grumman $(NOC)$, and Raytheon Technologies $(RTX)$ also qualify.","news_type":1},"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3551283870649340","authorId":"3551283870649340","authorIdStr":"3551283870649340","name":"Amy1224","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3551283870649340"},"content":"If you go up well, you can't see a decline","text":"If you go up well, you can't see a decline","html":"If you go up well, you can't see a decline"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168353403,"gmtCreate":1623953097902,"gmtModify":1703824603748,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Buy the dip!","listText":"Buy the dip!","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168353403","repostId":"2144405557","repostType":2,"repost":{"id":"2144405557","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623952545,"share":"https://ttm.financial/m/news/2144405557?lang=&edition=fundamental","pubTime":"2021-06-18 01:55","market":"us","language":"en","title":"US STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2144405557","media":"Reuters","summary":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news","content":"<html><body><p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p><p>   * New jobless claims up last week</p><p>   * CureVac tumbles on missing COVID-19 vaccine efficacy goal</p><p>   * Indexes: Dow down 0.5%, S&amp;P up 0.1%, Nasdaq gains 1%</p><p> (Adds details, updates prices)</p><p>   By Medha Singh and David French</p><p>   June 17 (Reuters) - The Nasdaq jumped on Thursday, at <a href=\"https://laohu8.com/S/AONE\">one</a> point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.</p><p>   The performance of the tech-heavy Nasdaq was in stark contrast to the S&amp;P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.</p><p>   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.</p><p>   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.</p><p>   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.  </p><p>   Still, shares of Apple Inc   , Microsoft Corp</p><p> , Amazon.com Inc    and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.</p><p>   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.</p><p>   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"</p><p>   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.</p><p>   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&amp;P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite</p><p>  added 127.04 points, or 0.9%, to 14,166.73.</p><p>   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.   </p><p>   The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&amp;P sectors.   </p><p>   Other economically sensitive stocks including materials</p><p>  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.  </p><p>   \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.</p><p>   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.  </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)</p><p>((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 01:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p><p>   * New jobless claims up last week</p><p>   * CureVac tumbles on missing COVID-19 vaccine efficacy goal</p><p>   * Indexes: Dow down 0.5%, S&amp;P up 0.1%, Nasdaq gains 1%</p><p> (Adds details, updates prices)</p><p>   By Medha Singh and David French</p><p>   June 17 (Reuters) - The Nasdaq jumped on Thursday, at <a href=\"https://laohu8.com/S/AONE\">one</a> point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.</p><p>   The performance of the tech-heavy Nasdaq was in stark contrast to the S&amp;P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.</p><p>   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.</p><p>   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.</p><p>   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.  </p><p>   Still, shares of Apple Inc   , Microsoft Corp</p><p> , Amazon.com Inc    and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.</p><p>   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.</p><p>   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"</p><p>   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.</p><p>   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&amp;P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite</p><p>  added 127.04 points, or 0.9%, to 14,166.73.</p><p>   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.   </p><p>   The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&amp;P sectors.   </p><p>   Other economically sensitive stocks including materials</p><p>  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.  </p><p>   \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.</p><p>   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.  </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)</p><p>((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SCHW":"嘉信理财","NDAQ":"纳斯达克OMX交易所"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144405557","content_text":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)   * New jobless claims up last week   * CureVac tumbles on missing COVID-19 vaccine efficacy goal   * Indexes: Dow down 0.5%, S&P up 0.1%, Nasdaq gains 1% (Adds details, updates prices)   By Medha Singh and David French   June 17 (Reuters) - The Nasdaq jumped on Thursday, at one point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.   The performance of the tech-heavy Nasdaq was in stark contrast to the S&P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.     Still, shares of Apple Inc   , Microsoft Corp , Amazon.com Inc    and Facebook Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite  added 127.04 points, or 0.9%, to 14,166.73.   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.      The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&P sectors.      Other economically sensitive stocks including materials  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.     \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.      <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168333096,"gmtCreate":1623949477115,"gmtModify":1703824535988,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Meme stocks","listText":"Meme stocks","text":"Meme stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/168333096","repostId":"1137716821","repostType":4,"repost":{"id":"1137716821","pubTimestamp":1623940600,"share":"https://ttm.financial/m/news/1137716821?lang=&edition=fundamental","pubTime":"2021-06-17 22:36","market":"us","language":"en","title":"With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1137716821","media":"benzinga","summary":"It seems that the market debate about whether inflation is truly temporary or could be more lingerin","content":"<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.</p>\n<p>The Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.</p>\n<p>But really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.</p>\n<p>So all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.</p>\n<p>In earnings news this morning, grocery giant&nbsp;<b>Kroger</b>&nbsp;rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder&nbsp;<b>Lennar</b>&nbsp;are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember:&nbsp;Homebuilders have had a tough time&nbsp;navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.</p>\n<p>Another stock in the green—literally and figuratively—is&nbsp;<b>Ford</b>&nbsp;, which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker&nbsp;<b>General Motors</b>GM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.</p>\n<p>A (Somewhat) Jarring Jolt</p>\n<p>Yesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.</p>\n<p>These moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.</p>\n<p>Seven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.</p>\n<p>But stocks did recover somewhat yesterday, and the laggard&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;($DJI) was able to regain the 34,000 mark when all was said and done.</p>\n<p>Is It Worth A&nbsp;Taper Tantrum?</p>\n<p>Even though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.</p>\n<p>The Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”</p>\n<p>Fed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.</p>\n<p><b>CHART OF THE DAY: IN TANDEM:</b>The&nbsp;<b>US dollar index</b>&nbsp;($DXY—purple line) and&nbsp;<b>10-Year Treasury Note Yield Index</b>&nbsp;(TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The&nbsp;thinkorswim® platform.&nbsp;<i>For illustrative purposes only. Past performance does not guarantee future results.</i></p>\n<p><b>ESG Debt Accelerating:</b>It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.</p>\n<p>That sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.</p>\n<p><b>Charging Up:</b>Continuing with the sustainability theme, it may seem that&nbsp;<b>Tesla</b>&nbsp;dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like&nbsp;<b>Kandi Technologies Group</b>&nbsp;,&nbsp;<b>Li Auto</b>&nbsp;, and&nbsp;<b>NIO</b>&nbsp;but also from traditional automakers like&nbsp;<b>General Motors</b>&nbsp;and&nbsp;<b>Ford</b>&nbsp;. Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.</p>\n<p><b>Catching The Bus:</b>But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is&nbsp;<b>Lion Electric</b>&nbsp;. According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.</p>\n<p>“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV,&nbsp;<b>Arrival</b>ARVL 6.42%,&nbsp;<b>BYD Co.</b>&nbsp;(OTCMKTS: BYDDY),&nbsp;<b>Nikola Corp.</b>&nbsp;. And yes, lest we forget, TSLA has been working on an electric semi-truck for years.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","TSLA":"特斯拉","KR":"克罗格"},"source_url":"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137716821","content_text":"It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.\nBut really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.\nSo all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.\nIn earnings news this morning, grocery giant Kroger rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder Lennar are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember: Homebuilders have had a tough time navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.\nAnother stock in the green—literally and figuratively—is Ford , which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker General MotorsGM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.\nA (Somewhat) Jarring Jolt\nYesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.\nThese moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.\nSeven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.\nBut stocks did recover somewhat yesterday, and the laggard Dow Jones Industrial Average ($DJI) was able to regain the 34,000 mark when all was said and done.\nIs It Worth A Taper Tantrum?\nEven though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.\nThe Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”\nFed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.\nCHART OF THE DAY: IN TANDEM:The US dollar index ($DXY—purple line) and 10-Year Treasury Note Yield Index (TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.\nESG Debt Accelerating:It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.\nThat sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.\nCharging Up:Continuing with the sustainability theme, it may seem that Tesla dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like Kandi Technologies Group , Li Auto , and NIO but also from traditional automakers like General Motors and Ford . Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.\nCatching The Bus:But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is Lion Electric . According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.\n“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV, ArrivalARVL 6.42%, BYD Co. (OTCMKTS: BYDDY), Nikola Corp. . And yes, lest we forget, TSLA has been working on an electric semi-truck for years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168339605,"gmtCreate":1623949448907,"gmtModify":1703824534994,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"A lot of potential","listText":"A lot of potential","text":"A lot of potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168339605","repostId":"1175322624","repostType":4,"repost":{"id":"1175322624","pubTimestamp":1623940991,"share":"https://ttm.financial/m/news/1175322624?lang=&edition=fundamental","pubTime":"2021-06-17 22:43","market":"us","language":"en","title":"Fisker Jumps on EV-Production Pact With Magna International","url":"https://stock-news.laohu8.com/highlight/detail?id=1175322624","media":".thestreet","summary":"Fisker   was higher after it said it signed an agreement under which Magna International,  the mobility technology company, would produce its electric vehicles.As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik F","content":"<p>Fisker&nbsp;(<b>FSR</b>) &nbsp;was higher after it&nbsp;said&nbsp;it signed an agreement under which Magna International,&nbsp;(<b>MGA</b>)&nbsp;the mobility technology company, would produce its electric vehicles.</p>\n<p>As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.</p>\n<p>\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.</p>\n<p>The Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.</p>\n<p>The agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.</p>\n<p>The Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.</p>\n<p>Fisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below&nbsp;€32,000 ($38,200) in Germany (including taxes and EV-related subsidies).</p>\n<p>\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.</p>\n<p>Fisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fisker Jumps on EV-Production Pact With Magna International</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFisker Jumps on EV-Production Pact With Magna International\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement><strong>.thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, ...</p>\n\n<a href=\"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSR":"菲斯克"},"source_url":"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175322624","content_text":"Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\n\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.\nThe Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.\nThe agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.\nThe Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.\nFisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below €32,000 ($38,200) in Germany (including taxes and EV-related subsidies).\n\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.\nFisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330740,"gmtCreate":1623949416480,"gmtModify":1703824533510,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Great job","listText":"Great job","text":"Great job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330740","repostId":"2144749073","repostType":4,"repost":{"id":"2144749073","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623938100,"share":"https://ttm.financial/m/news/2144749073?lang=&edition=fundamental","pubTime":"2021-06-17 21:55","market":"us","language":"en","title":"Google's cloud taps AMD for new service as chip wars heat up","url":"https://stock-news.laohu8.com/highlight/detail?id=2144749073","media":"Reuters","summary":"June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Goog","content":"<p>June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on <a href=\"https://laohu8.com/S/AMD\">AMD</a>'s newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .</p>\n<p>Cloud computing providers such as Google, Amazon.com Inc&nbsp;and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.</p>\n<p>Google said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as <a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a> and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc&nbsp;are testing the new AMD-based services.</p>\n<p>AMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.</p>\n<p>Intel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google's cloud taps AMD for new service as chip wars heat up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle's cloud taps AMD for new service as chip wars heat up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-17 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on <a href=\"https://laohu8.com/S/AMD\">AMD</a>'s newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .</p>\n<p>Cloud computing providers such as Google, Amazon.com Inc&nbsp;and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.</p>\n<p>Google said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as <a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a> and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc&nbsp;are testing the new AMD-based services.</p>\n<p>AMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.</p>\n<p>Intel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","GOOGL":"谷歌A","SNAP":"Snap Inc","INTC":"英特尔","AMZN":"亚马逊","AMD":"美国超微公司","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144749073","content_text":"June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on AMD's newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .\nCloud computing providers such as Google, Amazon.com Inc and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.\nGoogle said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as Snap Inc and Twitter Inc are testing the new AMD-based services.\nAMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.\nIntel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330994,"gmtCreate":1623949381818,"gmtModify":1703824532366,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Yeah right","listText":"Yeah right","text":"Yeah right","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330994","repostId":"2144744636","repostType":4,"repost":{"id":"2144744636","pubTimestamp":1623940250,"share":"https://ttm.financial/m/news/2144744636?lang=&edition=fundamental","pubTime":"2021-06-17 22:30","market":"us","language":"en","title":"Low dosage may be behind low efficacy of CureVac vaccine: Study leader","url":"https://stock-news.laohu8.com/highlight/detail?id=2144744636","media":"The Straits Times","summary":"BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disa","content":"<div>\n<p>BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Low dosage may be behind low efficacy of CureVac vaccine: Study leader</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLow dosage may be behind low efficacy of CureVac vaccine: Study leader\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVAC":"CureVac B.V."},"source_url":"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144744636","content_text":"BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said on Thursday (June 17).\nThe German biotech's vaccine proved only 47 per cent effective in an initial trial, far lower than those of rivals BioNTech/Pfizer and Moderna, which are also based on mRNA technology and had efficacy rates well above 90 per cent.\nDr Peter Kremsner from the University Hospital in Tuebingen which is running the trial, told Reuters the low efficacy is \"very likely due to the dose\".\nUnlike BioNTech and Moderna, CureVac did not modify the mRNA used in the shots and therefore a higher dosage was not possible because of the side effects to be expected, Dr Kremsner said.\nWith just 12 micrograms of mRNA per dose, the company has been seeking to position itself as a low-dose alternative to BioNTech and Moderna's established shots with 30 and 100 micrograms per shot, respectively.\nIt is also easy to store and cheaper than the other mRNA shots too.\nThe European Union has agreed to pay 12 euros (S$19.20) per dose for supplies of the shot, an EU internal document shows, but has paid more than 15 euros for the other mRNA shots.\nHowever, the interim trial analysis goes some way to challenging the expectation, which was previously reflected in the company's share price, that all mRNA vaccines are similar.\nThe news wiped as much as 52 per cent off the company's value on Thursday.\nCureVac said on Wednesday that new variants had proved a headwind, but data from BioNTech and Moderna have, however, so far suggested only somewhat weaker protection against new variants.\nDr Kremsner said he thought it was probably a \"long shot\" as to whether CureVac's vaccine might turn out to be more effective when targeting a particular variant.\nThe disappointing results are a blow since European governments had been hoping to add it to their arsenal after age limits were imposed on the use of the Johnson & Johnson and AstraZeneca vaccines due to a link to extremely rare but potentially fatal clotting disorders.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168397628,"gmtCreate":1623949351164,"gmtModify":1703824533842,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168397628","repostId":"2144374429","repostType":4,"repost":{"id":"2144374429","weMediaInfo":{"introduction":"用于AMD抓取企业号","home_visible":0,"media_name":"AMD官方ir","id":"1033719607","head_image":"https://static.tigerbbs.com/d091d76cf1bfa1d333bf377a4304e13d"},"pubTimestamp":1623940320,"share":"https://ttm.financial/m/news/2144374429?lang=&edition=fundamental","pubTime":"2021-06-17 22:32","market":"us","language":"en","title":"Google Selects 3rd Gen AMD EPYC™ Processors to Launch First Tau VM Instance","url":"https://stock-news.laohu8.com/highlight/detail?id=2144374429","media":"AMD官方ir","summary":"AMD EPYC processors enable Google Cloud to provide customers with industry leading performance and price-performance for scale-out workloads ","content":"<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> (NASDAQ: AMD) and Google Cloud today announced T2D, the first instance in the new family of Tau Virtual Machines (VMs) powered by 3rd Gen AMD EPYC™ processors. According to Google Cloud, the T2D instance offers 56% higher absolute performance and more than 40% higher price performance for scale-out workloads1.</p>\n<p>The Tau VM family provides customers with a leading combination of performance, price, and easy integration. The T2D instances, using the leadership performance of 3rd Gen AMD EPYC processors, excels at workloads including web servers, containerized microservices, data logging-processing, large scale Java® applications and more.</p>\n<p>“At Google Cloud, our customers’ compute needs are evolving,” said Thomas Kurian, CEO of Google Cloud. “By collaborating with AMD, Google Cloud customers can now leverage amazing performance for scale-out applications, with great price-performance, all without compromising x86 compatibility.”</p>\n<p>“We designed 3rd Gen AMD EPYC processors to meet the growing demand from cloud and enterprise customers for high-performance, cost-effective solutions with optimal TCO,” said AMD President and CEO Dr. Lisa Su. “We work closely with Google Cloud and are proud they selected AMD to exclusively power the new Tau VM T2D instance which provides customers with powerful new options to run their most demanding scale-out workloads.”</p>\n<p>The industry-leading2&nbsp;3rd Gen AMD EPYC processors allow Google Cloud customers to seamlessly integrate workloads with their existing x86 ecosystems, enabling applications and frameworks to work with the T2D instances. The new instances are offered in eight different predefined VM shapes, with up to 60 vCPUs per VM, and up to 4GB of memory per vCPU, making this technology ideal for scale-out workloads.</p>\n<p>AMD EPYC processors power numerous instances at Google Cloud that support workloads including compute optimized, general purpose, high-performance and confidential computing. These instances are used by well-known cloud-native companies, spanning multiple industries, providing high-performance cloud instances for their workloads.</p>\n<p>T2D instances will be available in Q3 and customers can sign up for a preview here.</p>\n<h3>Supporting Resources</h3>\n<ul>\n <li>\n  <ul>\n   <li>Learn more about AMD EPYC Processors</li>\n   <li>See demos, videos and more about the AMD EPYC 7003 series processors</li>\n   <li>Learn more about the Google T2D Instance and Tau VMs</li>\n   <li>Follow AMD on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></li>\n  </ul></li>\n</ul>\n<h3>About AMD</h3>\n<p>For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, <a href=\"https://laohu8.com/S/FB\">Facebook</a> and Twitter pages.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google Selects 3rd Gen AMD EPYC™ Processors to Launch First Tau VM Instance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle Selects 3rd Gen AMD EPYC™ Processors to Launch First Tau VM Instance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d091d76cf1bfa1d333bf377a4304e13d);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">AMD官方ir </p>\n<p class=\"h-time\">2021-06-17 22:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> (NASDAQ: AMD) and Google Cloud today announced T2D, the first instance in the new family of Tau Virtual Machines (VMs) powered by 3rd Gen AMD EPYC™ processors. According to Google Cloud, the T2D instance offers 56% higher absolute performance and more than 40% higher price performance for scale-out workloads1.</p>\n<p>The Tau VM family provides customers with a leading combination of performance, price, and easy integration. The T2D instances, using the leadership performance of 3rd Gen AMD EPYC processors, excels at workloads including web servers, containerized microservices, data logging-processing, large scale Java® applications and more.</p>\n<p>“At Google Cloud, our customers’ compute needs are evolving,” said Thomas Kurian, CEO of Google Cloud. “By collaborating with AMD, Google Cloud customers can now leverage amazing performance for scale-out applications, with great price-performance, all without compromising x86 compatibility.”</p>\n<p>“We designed 3rd Gen AMD EPYC processors to meet the growing demand from cloud and enterprise customers for high-performance, cost-effective solutions with optimal TCO,” said AMD President and CEO Dr. Lisa Su. “We work closely with Google Cloud and are proud they selected AMD to exclusively power the new Tau VM T2D instance which provides customers with powerful new options to run their most demanding scale-out workloads.”</p>\n<p>The industry-leading2&nbsp;3rd Gen AMD EPYC processors allow Google Cloud customers to seamlessly integrate workloads with their existing x86 ecosystems, enabling applications and frameworks to work with the T2D instances. The new instances are offered in eight different predefined VM shapes, with up to 60 vCPUs per VM, and up to 4GB of memory per vCPU, making this technology ideal for scale-out workloads.</p>\n<p>AMD EPYC processors power numerous instances at Google Cloud that support workloads including compute optimized, general purpose, high-performance and confidential computing. These instances are used by well-known cloud-native companies, spanning multiple industries, providing high-performance cloud instances for their workloads.</p>\n<p>T2D instances will be available in Q3 and customers can sign up for a preview here.</p>\n<h3>Supporting Resources</h3>\n<ul>\n <li>\n  <ul>\n   <li>Learn more about AMD EPYC Processors</li>\n   <li>See demos, videos and more about the AMD EPYC 7003 series processors</li>\n   <li>Learn more about the Google T2D Instance and Tau VMs</li>\n   <li>Follow AMD on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></li>\n  </ul></li>\n</ul>\n<h3>About AMD</h3>\n<p>For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, <a href=\"https://laohu8.com/S/FB\">Facebook</a> and Twitter pages.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144374429","content_text":"AMD (NASDAQ: AMD) and Google Cloud today announced T2D, the first instance in the new family of Tau Virtual Machines (VMs) powered by 3rd Gen AMD EPYC™ processors. According to Google Cloud, the T2D instance offers 56% higher absolute performance and more than 40% higher price performance for scale-out workloads1.\nThe Tau VM family provides customers with a leading combination of performance, price, and easy integration. The T2D instances, using the leadership performance of 3rd Gen AMD EPYC processors, excels at workloads including web servers, containerized microservices, data logging-processing, large scale Java® applications and more.\n“At Google Cloud, our customers’ compute needs are evolving,” said Thomas Kurian, CEO of Google Cloud. “By collaborating with AMD, Google Cloud customers can now leverage amazing performance for scale-out applications, with great price-performance, all without compromising x86 compatibility.”\n“We designed 3rd Gen AMD EPYC processors to meet the growing demand from cloud and enterprise customers for high-performance, cost-effective solutions with optimal TCO,” said AMD President and CEO Dr. Lisa Su. “We work closely with Google Cloud and are proud they selected AMD to exclusively power the new Tau VM T2D instance which provides customers with powerful new options to run their most demanding scale-out workloads.”\nThe industry-leading2 3rd Gen AMD EPYC processors allow Google Cloud customers to seamlessly integrate workloads with their existing x86 ecosystems, enabling applications and frameworks to work with the T2D instances. The new instances are offered in eight different predefined VM shapes, with up to 60 vCPUs per VM, and up to 4GB of memory per vCPU, making this technology ideal for scale-out workloads.\nAMD EPYC processors power numerous instances at Google Cloud that support workloads including compute optimized, general purpose, high-performance and confidential computing. These instances are used by well-known cloud-native companies, spanning multiple industries, providing high-performance cloud instances for their workloads.\nT2D instances will be available in Q3 and customers can sign up for a preview here.\nSupporting Resources\n\n\n\nLearn more about AMD EPYC Processors\nSee demos, videos and more about the AMD EPYC 7003 series processors\nLearn more about the Google T2D Instance and Tau VMs\nFollow AMD on Twitter\n\n\nAbout AMD\nFor more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, Facebook and Twitter pages.","news_type":1},"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168394705,"gmtCreate":1623949324907,"gmtModify":1703824531046,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Bump bump bup","listText":"Bump bump bup","text":"Bump bump bup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168394705","isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168391821,"gmtCreate":1623949059663,"gmtModify":1703824522464,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Brilliant","listText":"Brilliant","text":"Brilliant","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168391821","repostId":"1108846547","repostType":4,"repost":{"id":"1108846547","pubTimestamp":1623943021,"share":"https://ttm.financial/m/news/1108846547?lang=&edition=fundamental","pubTime":"2021-06-17 23:17","market":"us","language":"en","title":"Why Bankers Just Complicated El Salvador’s Bitcoin Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1108846547","media":"investorplace","summary":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused E","content":"<p>The price of<b>Bitcoin</b>(CCC:<b><u>BTC-USD</u></b>) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.</p>\n<p>Last week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :</p>\n<p>He deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:</p>\n<blockquote>\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n</blockquote>\n<p>Yet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender told<i>Reuters</i>.</p>\n<p>“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”</p>\n<p>El Salvador Bitcoin Plan Would Be a First</p>\n<p>El Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as&nbsp;only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.</p>\n<p>What else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?</p>\n<ul>\n <li>The government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.</li>\n <li>This fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.</li>\n <li>In addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.</li>\n <li>He said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.</li>\n</ul>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Bankers Just Complicated El Salvador’s Bitcoin Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Bankers Just Complicated El Salvador’s Bitcoin Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The ...</p>\n\n<a href=\"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust"},"source_url":"https://investorplace.com/2021/06/world-bank-crypto-news-why-bankers-just-complicated-el-salvadors-bitcoin-plan/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108846547","content_text":"The price ofBitcoin(CCC:BTC-USD) slipped to below $39,000 on Thursday after the World Bank refused El Salvador’s request to help with the implementation of the cryptocurrency as a legal tender. The value of BTC has depreciated about 0.4% in the last 24 hours.\nLast week, the Latin American country’s president, Nayib Bukele, tweeted a reveal of his El Salvador Bitcoin plan :\nHe deflected concerns about the cryptocurrency’s environmental impact with another tweet that indicated the country would use clean energy for mining:\n\n “Our engineers just informed me that they dug a new well, that will provide approximately 95MW of 100% clean, 0 emissions geothermal energy from our volcanosStarting to design a full#Bitcoinmining hub around it.”\n\nYet that wasn’t enough to prevent theWorld Bank crypto kibosh. The lender said it could not assist El Salvador’s Bitcoin plan due to the environmental impact of mining and transparency challenges. “We are committed to helping El Salvador in numerous ways including for currency transparency and regulatory processes,” a spokesperson for the international lender toldReuters.\n“While the government did approach us for assistance on Bitcoin, this is not something the World Bank can support given the environmental and transparency shortcomings.”\nEl Salvador Bitcoin Plan Would Be a First\nEl Salvador is looking to offermore financial freedomto citizens who might not have access to traditional financial services. That makes sense as only 30% of citizens have access to such services. Folks there won’t have to use a government wallet to hold BTC. And while all businesses will have to accept Bitcoin, they won’t necessarily have to hold onto it.\nWhat else is inthe El Salvador Bitcoin plan, which makes the country the first in the world to accept the cryptocurrency as legal tender?\n\nThe government is setting up a fund that will allow businesses to exchange BTC for U.S. dollars.\nThis fund will hold $150 million and will regularly sell Bitcoin to replenish its resources.\nIn addition to all of this, Bukele also revealed that investing in the economy of El Salvador can grant a person citizenship.\nHe said that anyone that invests 3 BTC, or about $117,0000 as of this writing, into the economy will obtain citizenship in the country.","news_type":1},"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":166641861,"gmtCreate":1624008197353,"gmtModify":1703826426041,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Ford looks good to buy&nbsp;","listText":"Ford looks good to buy&nbsp;","text":"Ford looks good to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641861","repostId":"2144172072","repostType":4,"repost":{"id":"2144172072","pubTimestamp":1624007350,"share":"https://ttm.financial/m/news/2144172072?lang=&edition=fundamental","pubTime":"2021-06-18 17:09","market":"us","language":"en","title":"Old car makers are the hot new trade: Morning Brief","url":"https://stock-news.laohu8.com/highlight/detail?id=2144172072","media":"Yahoo Finance","summary":"The past is outperforming the future this year.\nWe're less than a week out from the halfway point of","content":"<p>The past is outperforming the future this year.</p>\n<p>We're less than a week out from the halfway point of 2021.</p>\n<p>And <a href=\"https://laohu8.com/S/AONE\">one</a> of the big real economy stories this year has been the explosion in demand for cars. This has pushed up prices, particularly for used cars.</p>\n<p>And while most used cars, and those on the road today, are running on internal combustion engines (ICE), the industry agrees that electric vehicles (EVs) are the future. For the last decade, the best way to play that trend has been via Tesla (TSLA). Shareholders in that particular trade have been rewarded handsomely: since June 2011, the car maker's shares are up over 10,000%.</p>\n<p>This year, however, investors have been betting that the industry's old guard can make their businesses work better in an electrified future.</p>\n<p>Through Thursday's close, shares of Ford (F) and General Motors (GM) were both up more than 40%, outpacing both the broader market and all of the market's buzziest names in the EV space.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b210f3a56c6cba72ed1fbbf47bd815c\" tg-width=\"1230\" tg-height=\"498\" referrerpolicy=\"no-referrer\"><span>Ford and GM have been the leading auto stocks in 2021 as investors bet they can benefit in a growing economy and see returns from big investments in electric cars. (Source: Yahoo Finance)</span></p>\n<p>At an industry conference on Thursday, Ford CEO Jim Farley said the company's second quarter earnings were likely to come in better than expected. Earlier this week, GM announced that it would increase its investment in electric vehicles to $35 billion from $27 billion through 2025.</p>\n<p>And it was only a few weeks back that Ford announced its own ambitious plans to electrify more of its fleet, unveiling an electric F-150, its best-selling ICE vehicle, while unveiling plans to invest $30 billion in electric vehicle development over the next five years.</p>\n<p>This year's rally in shares of GM and Ford also remind us (in yet another way) how different this recovery has been from what we endured after the financial crisis.</p>\n<p>GM and Chrysler went bankrupt during the 2008-09 recession; Ford just barely staved off that fate. This time around, these companies are parlaying a surge in consumer demand into increased investments in trying to keep up with the Teslas of the world.</p>\n<p>These announcements out of Ford and GM also come as upstart competitors like Nikola (NKLA) and Lordstown Motors (RIDE) struggle to accurately communicate with investors. Nikola shares, which fell over 50% in 2020, were up about 11% this year through Thursday's close, while Lordstown's stock has been just about cut in half this year. Both Nikola and Lordstown replaced their chief executives after bold pronouncements about orders and capabilities for their vehicles didn't check out.</p>\n<p>Elon Musk's iconoclastic style at Tesla is much imitated but never duplicated by companies hoping to position themselves as the \"next Tesla.\" Tesla's Technoking really is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of one.</p>\n<p>In the years before the pandemic, Tesla's rise and the industry's electrified future pressured shares of Ford, GM, and other automakers. From the time GM emerged from bankruptcy in the fall of 2010, shares of both GM and Ford were trounced by the overall market. This year's gain does not erase that underperformance. And the lead the traditional auto industry has staked on Tesla becoming the leading electric vehicle brand will be hard to overcome.</p>\n<p>But today, what investors seem to see in Ford and GM is at least a chance. A chance to benefit from the post-pandemic economic expansion. And a chance at remaining a major player in the electrified auto market of tomorrow.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Old car makers are the hot new trade: Morning Brief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOld car makers are the hot new trade: Morning Brief\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The past is outperforming the future this year.\nWe're less than a week out from the halfway point of 2021.\nAnd one of the big real economy stories this year has been the explosion in demand for cars. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KNSL":"Kinsale Capital Group Inc.","F":"福特汽车","GM":"通用汽车","NKLA":"Nikola Corporation","TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/old-car-makers-are-the-hot-new-trade-morning-brief-090010592.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2144172072","content_text":"The past is outperforming the future this year.\nWe're less than a week out from the halfway point of 2021.\nAnd one of the big real economy stories this year has been the explosion in demand for cars. This has pushed up prices, particularly for used cars.\nAnd while most used cars, and those on the road today, are running on internal combustion engines (ICE), the industry agrees that electric vehicles (EVs) are the future. For the last decade, the best way to play that trend has been via Tesla (TSLA). Shareholders in that particular trade have been rewarded handsomely: since June 2011, the car maker's shares are up over 10,000%.\nThis year, however, investors have been betting that the industry's old guard can make their businesses work better in an electrified future.\nThrough Thursday's close, shares of Ford (F) and General Motors (GM) were both up more than 40%, outpacing both the broader market and all of the market's buzziest names in the EV space.\nFord and GM have been the leading auto stocks in 2021 as investors bet they can benefit in a growing economy and see returns from big investments in electric cars. (Source: Yahoo Finance)\nAt an industry conference on Thursday, Ford CEO Jim Farley said the company's second quarter earnings were likely to come in better than expected. Earlier this week, GM announced that it would increase its investment in electric vehicles to $35 billion from $27 billion through 2025.\nAnd it was only a few weeks back that Ford announced its own ambitious plans to electrify more of its fleet, unveiling an electric F-150, its best-selling ICE vehicle, while unveiling plans to invest $30 billion in electric vehicle development over the next five years.\nThis year's rally in shares of GM and Ford also remind us (in yet another way) how different this recovery has been from what we endured after the financial crisis.\nGM and Chrysler went bankrupt during the 2008-09 recession; Ford just barely staved off that fate. This time around, these companies are parlaying a surge in consumer demand into increased investments in trying to keep up with the Teslas of the world.\nThese announcements out of Ford and GM also come as upstart competitors like Nikola (NKLA) and Lordstown Motors (RIDE) struggle to accurately communicate with investors. Nikola shares, which fell over 50% in 2020, were up about 11% this year through Thursday's close, while Lordstown's stock has been just about cut in half this year. Both Nikola and Lordstown replaced their chief executives after bold pronouncements about orders and capabilities for their vehicles didn't check out.\nElon Musk's iconoclastic style at Tesla is much imitated but never duplicated by companies hoping to position themselves as the \"next Tesla.\" Tesla's Technoking really is one of one.\nIn the years before the pandemic, Tesla's rise and the industry's electrified future pressured shares of Ford, GM, and other automakers. From the time GM emerged from bankruptcy in the fall of 2010, shares of both GM and Ford were trounced by the overall market. This year's gain does not erase that underperformance. And the lead the traditional auto industry has staked on Tesla becoming the leading electric vehicle brand will be hard to overcome.\nBut today, what investors seem to see in Ford and GM is at least a chance. A chance to benefit from the post-pandemic economic expansion. And a chance at remaining a major player in the electrified auto market of tomorrow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351085,"gmtCreate":1623953132847,"gmtModify":1703824603910,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Apple will dip all the way","listText":"Apple will dip all the way","text":"Apple will dip all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/168351085","repostId":"2144745081","repostType":2,"repost":{"id":"2144745081","pubTimestamp":1623999815,"share":"https://ttm.financial/m/news/2144745081?lang=&edition=fundamental","pubTime":"2021-06-18 15:03","market":"us","language":"en","title":"Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say","url":"https://stock-news.laohu8.com/highlight/detail?id=2144745081","media":"MarketWatch","summary":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indicatio","content":"<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.</p>\n<p>\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.</p>\n<p>Fraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.</p>\n<p>Companies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.</p>\n<p>According to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.</p>\n<p>\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.</p>\n<p>\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1aca07448aa8168cf9edc9e49d933435\" tg-width=\"1260\" tg-height=\"672\" referrerpolicy=\"no-referrer\"><span>CHART VIA BERNSTEIN RESEARCH.</span></p>\n<p>There are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, and Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, as well as other technology companies like videogame developer Electronic Arts <a href=\"https://laohu8.com/S/EA\">$(EA)$</a> and semiconductor groups Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>, and Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>.</p>\n<p>Telecom giants AT&amp;T <a href=\"https://laohu8.com/S/T\">$(T)$</a> and Verizon <a href=\"https://laohu8.com/S/VZ\">$(VZ)$</a> are also on the list, as are retailers and consumer-products groups such as Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, Target <a href=\"https://laohu8.com/S/TGT\">$(TGT)$</a>, McDonalds <a href=\"https://laohu8.com/S/MCD\">$(MCD)$</a>, Starbucks <a href=\"https://laohu8.com/S/SBUX\">$(SBUX)$</a>, Nike <a href=\"https://laohu8.com/S/NKE\">$(NKE)$</a>, Kraft Heinz <a href=\"https://laohu8.com/S/KHC\">$(KHC)$</a>, Estée Lauder <a href=\"https://laohu8.com/S/EL\">$(EL)$</a>, and Coca-Cola <a href=\"https://laohu8.com/S/KO\">$(KO)$</a>.</p>\n<p>Health and biotechnology stocks like Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, Gilead Sciences <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a>, Regeneron <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a>, and Biogen <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> also make the cut, as do railroad operators Kansas City Southern <a href=\"https://laohu8.com/S/KSU\">$(KSU)$</a> and Union Pacific <a href=\"https://laohu8.com/S/UNP\">$(UNP)$</a>. Defense companies Lockheed Martin <a href=\"https://laohu8.com/S/LMT\">$(LMT)$</a>, Northrop Grumman <a href=\"https://laohu8.com/S/NOC\">$(NOC)$</a>, and Raytheon Technologies <a href=\"https://laohu8.com/S/RTX\">$(RTX)$</a> also qualify.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLooking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert...</p>\n\n<a href=\"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","RTX":"雷神技术公司","GILD":"吉利德科学","EA":"艺电","TGT":"塔吉特","NKE":"耐克","VZ":"威瑞森","HD":"家得宝","REGN":"再生元制药公司","AMZN":"亚马逊","AAPL":"苹果","KO":"可口可乐","LMT":"洛克希德马丁","GOOGL":"谷歌A","GOOG":"谷歌","SBUX":"星巴克","KHC":"卡夫亨氏","NOC":"诺斯罗普格鲁曼","MCD":"麦当劳","KSU":"堪萨斯南方铁路","UNP":"联合太平洋","EL":"雅诗兰黛","NVDA":"英伟达","PFE":"辉瑞","TXN":"德州仪器","QCOM":"高通","MSFT":"微软"},"source_url":"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144745081","content_text":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.\n\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.\nFraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.\nCompanies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.\nAccording to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.\n\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.\n\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.\nCHART VIA BERNSTEIN RESEARCH.\nThere are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple $(AAPL)$, Alphabet $(GOOGL)$(GOOGL), Amazon $(AMZN)$, and Microsoft $(MSFT)$, as well as other technology companies like videogame developer Electronic Arts $(EA)$ and semiconductor groups Nvidia $(NVDA)$, Texas Instruments $(TXN)$, and Qualcomm $(QCOM)$.\nTelecom giants AT&T $(T)$ and Verizon $(VZ)$ are also on the list, as are retailers and consumer-products groups such as Home Depot $(HD)$, Target $(TGT)$, McDonalds $(MCD)$, Starbucks $(SBUX)$, Nike $(NKE)$, Kraft Heinz $(KHC)$, Estée Lauder $(EL)$, and Coca-Cola $(KO)$.\nHealth and biotechnology stocks like Johnson & Johnson $(JNJ)$, Pfizer $(PFE)$, Gilead Sciences $(GILD)$, Regeneron $(REGN)$, and Biogen $(BIIB)$ also make the cut, as do railroad operators Kansas City Southern $(KSU)$ and Union Pacific $(UNP)$. Defense companies Lockheed Martin $(LMT)$, Northrop Grumman $(NOC)$, and Raytheon Technologies $(RTX)$ also qualify.","news_type":1},"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3551283870649340","authorId":"3551283870649340","authorIdStr":"3551283870649340","name":"Amy1224","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3551283870649340"},"content":"If you go up well, you can't see a decline","text":"If you go up well, you can't see a decline","html":"If you go up well, you can't see a decline"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168333096,"gmtCreate":1623949477115,"gmtModify":1703824535988,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Meme stocks","listText":"Meme stocks","text":"Meme stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/168333096","repostId":"1137716821","repostType":4,"repost":{"id":"1137716821","pubTimestamp":1623940600,"share":"https://ttm.financial/m/news/1137716821?lang=&edition=fundamental","pubTime":"2021-06-17 22:36","market":"us","language":"en","title":"With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1137716821","media":"benzinga","summary":"It seems that the market debate about whether inflation is truly temporary or could be more lingerin","content":"<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.</p>\n<p>The Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.</p>\n<p>But really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.</p>\n<p>So all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.</p>\n<p>In earnings news this morning, grocery giant&nbsp;<b>Kroger</b>&nbsp;rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder&nbsp;<b>Lennar</b>&nbsp;are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember:&nbsp;Homebuilders have had a tough time&nbsp;navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.</p>\n<p>Another stock in the green—literally and figuratively—is&nbsp;<b>Ford</b>&nbsp;, which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker&nbsp;<b>General Motors</b>GM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.</p>\n<p>A (Somewhat) Jarring Jolt</p>\n<p>Yesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.</p>\n<p>These moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.</p>\n<p>Seven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.</p>\n<p>But stocks did recover somewhat yesterday, and the laggard&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;($DJI) was able to regain the 34,000 mark when all was said and done.</p>\n<p>Is It Worth A&nbsp;Taper Tantrum?</p>\n<p>Even though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.</p>\n<p>The Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”</p>\n<p>Fed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.</p>\n<p><b>CHART OF THE DAY: IN TANDEM:</b>The&nbsp;<b>US dollar index</b>&nbsp;($DXY—purple line) and&nbsp;<b>10-Year Treasury Note Yield Index</b>&nbsp;(TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The&nbsp;thinkorswim® platform.&nbsp;<i>For illustrative purposes only. Past performance does not guarantee future results.</i></p>\n<p><b>ESG Debt Accelerating:</b>It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.</p>\n<p>That sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.</p>\n<p><b>Charging Up:</b>Continuing with the sustainability theme, it may seem that&nbsp;<b>Tesla</b>&nbsp;dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like&nbsp;<b>Kandi Technologies Group</b>&nbsp;,&nbsp;<b>Li Auto</b>&nbsp;, and&nbsp;<b>NIO</b>&nbsp;but also from traditional automakers like&nbsp;<b>General Motors</b>&nbsp;and&nbsp;<b>Ford</b>&nbsp;. Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.</p>\n<p><b>Catching The Bus:</b>But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is&nbsp;<b>Lion Electric</b>&nbsp;. According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.</p>\n<p>“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV,&nbsp;<b>Arrival</b>ARVL 6.42%,&nbsp;<b>BYD Co.</b>&nbsp;(OTCMKTS: BYDDY),&nbsp;<b>Nikola Corp.</b>&nbsp;. And yes, lest we forget, TSLA has been working on an electric semi-truck for years.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","TSLA":"特斯拉","KR":"克罗格"},"source_url":"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137716821","content_text":"It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.\nBut really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.\nSo all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.\nIn earnings news this morning, grocery giant Kroger rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder Lennar are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember: Homebuilders have had a tough time navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.\nAnother stock in the green—literally and figuratively—is Ford , which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker General MotorsGM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.\nA (Somewhat) Jarring Jolt\nYesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.\nThese moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.\nSeven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.\nBut stocks did recover somewhat yesterday, and the laggard Dow Jones Industrial Average ($DJI) was able to regain the 34,000 mark when all was said and done.\nIs It Worth A Taper Tantrum?\nEven though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.\nThe Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”\nFed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.\nCHART OF THE DAY: IN TANDEM:The US dollar index ($DXY—purple line) and 10-Year Treasury Note Yield Index (TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.\nESG Debt Accelerating:It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.\nThat sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.\nCharging Up:Continuing with the sustainability theme, it may seem that Tesla dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like Kandi Technologies Group , Li Auto , and NIO but also from traditional automakers like General Motors and Ford . Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.\nCatching The Bus:But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is Lion Electric . According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.\n“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV, ArrivalARVL 6.42%, BYD Co. (OTCMKTS: BYDDY), Nikola Corp. . And yes, lest we forget, TSLA has been working on an electric semi-truck for years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641587,"gmtCreate":1624008226649,"gmtModify":1703826426373,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"This is so sad","listText":"This is so sad","text":"This is so sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641587","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166644647,"gmtCreate":1624008474089,"gmtModify":1703826433205,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Shell out more money","listText":"Shell out more money","text":"Shell out more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166644647","repostId":"1181667218","repostType":4,"repost":{"id":"1181667218","pubTimestamp":1624008124,"share":"https://ttm.financial/m/news/1181667218?lang=&edition=fundamental","pubTime":"2021-06-18 17:22","market":"us","language":"en","title":"ChargePoint’s Network Effects Will Make It the Next ‘Shell’","url":"https://stock-news.laohu8.com/highlight/detail?id=1181667218","media":"investorplace","summary":"ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May a","content":"<p><b>ChargePoint</b>&nbsp;(NYSE:<b><u>CHPT</u></b>) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed420b8993199e014fc4d87c875c9dd5\" tg-width=\"300\" tg-height=\"169\"><span>Source: YuniqueB / Shutterstock.com</span></p>\n<p>The catalyst? There are a few of them —</p>\n<ul>\n <li>Recharged growth trade on lower bond yields</li>\n <li>Reinvigorated optimism about EVs and the charging network buildout</li>\n <li>New, rather impressive products from ChargePoint</li>\n</ul>\n<p>This will all last. EVs will take over the world, charging stations will replace gas pumps and ChargePoint will be the biggest charging company in the world when all is said and done.</p>\n<p>Here’s why.</p>\n<p>ChargePoint is North America’s largest operator of electric vehicle charging stations. It should be able to leverage their early entry into the market as well as its size. Thanks to network effects, it could turn into the EV version of<b>Shell</b>(NYSE:<b><u>RDS-A</u></b>, NYSE:<b><u>RDS-B</u></b>) or<b>Exxon</b>(NYSE:<b><u>XOM</u></b>) by 2030.</p>\n<p>On the surface, this company looks like all other EV charging companies.</p>\n<p>ChargePoint operate on the standard hardware-plus-software model — selling both physical EV charging ports and end-to-end software platforms to manage them. Its assortment of chargers includes L2 chargers and a smattering of DC fast chargers. And it costs money, around $2 to $5, to use these chargers.</p>\n<p>Basically, ChargePoint is doing what everyone else is doing, but there’s so much more to it than that …</p>\n<p>CHPT Stock: Network Effects Set ChargePoint Apart</p>\n<p>Where ChargePoint shines is in its unparalleled size and dominance in the EV charging station market.</p>\n<p>It’s seven times larger than its nearest competitor, with over 100,000 charging ports and 73% of L2 EV charging stations.</p>\n<p>Its size is especially significant because of network effects.</p>\n<p>Of ChargePoint’s commercial clients, more than 60% of&nbsp;<b>Fortune 500</b>&nbsp;companies employ ChargePoint charging stations at their corporate offices. If companies such as<b>Facebook</b>(NASDAQ:<b><u>FB</u></b>),<b>Netflix</b>(NASDAQ:<b><u>NFLX</u></b>),<b>Salesforce</b>(NYSE:<b><u>CRM</u></b>),<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and<b>Adobe</b>(NASDAQ:<b><u>ADBE</u></b>) already utilize ChargePoint chargers — which shows other companies who to turn to when they want to install their own EV charging stations — ChargePoint should be able to leverage this array of existing customers to win more and more big-name contracts.</p>\n<p>ChargePoint is on its way to dominating the commercial workplace vertical of the EV market for the near- to long-term future.</p>\n<p>From a consumer-facing perspective, ChargePoint is also setting itself up for future success.</p>\n<p>The company hasteamed up with auto makerslike Mercedes-owner&nbsp;<b>Daimler AG</b>(OTCMKTS:<b><u>DMLRY</u></b>) and<b>BMW</b>(OTC:<b><u>BMWYY</u></b>) tointegrate the locations of its charging stationsinto in-car navigation systems.</p>\n<p>ChargePoint also offers a popular app that enables drivers to locate its charging stations, see if they’re currently in-use or not and check prices. The app keeps ChargePoint on consumers’ minds, which will help the company dominate the at-home, residential EV-charging market.</p>\n<p>Again, it all comes down to ChargePoint’s unmatched network effects.</p>\n<p>Which is why I believe that, as EVs gradually replace gas cars, ChargePoint has the potential to replace Shell as the leading operator of “refueling” stations.</p>\n<p>Naturally, that would mean huge upside potential for CHPT stock.</p>\n<p>Which is why CHPT is one of my top picks in EV charging. And long-term, you can bet that CHPT stock will score investors massive returns.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ChargePoint’s Network Effects Will Make It the Next ‘Shell’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChargePoint’s Network Effects Will Make It the Next ‘Shell’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.\nSource: YuniqueB / Shutterstock.com\nThe ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc."},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/06/chargepoints-network-effects-will-make-them-the-next-shell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181667218","content_text":"ChargePoint (NYSE:CHPT) stock took a bit hit in March and April but has bounced back nicely in May and June. It’s now pushing its way towards all-time highs.\nSource: YuniqueB / Shutterstock.com\nThe catalyst? There are a few of them —\n\nRecharged growth trade on lower bond yields\nReinvigorated optimism about EVs and the charging network buildout\nNew, rather impressive products from ChargePoint\n\nThis will all last. EVs will take over the world, charging stations will replace gas pumps and ChargePoint will be the biggest charging company in the world when all is said and done.\nHere’s why.\nChargePoint is North America’s largest operator of electric vehicle charging stations. It should be able to leverage their early entry into the market as well as its size. Thanks to network effects, it could turn into the EV version ofShell(NYSE:RDS-A, NYSE:RDS-B) orExxon(NYSE:XOM) by 2030.\nOn the surface, this company looks like all other EV charging companies.\nChargePoint operate on the standard hardware-plus-software model — selling both physical EV charging ports and end-to-end software platforms to manage them. Its assortment of chargers includes L2 chargers and a smattering of DC fast chargers. And it costs money, around $2 to $5, to use these chargers.\nBasically, ChargePoint is doing what everyone else is doing, but there’s so much more to it than that …\nCHPT Stock: Network Effects Set ChargePoint Apart\nWhere ChargePoint shines is in its unparalleled size and dominance in the EV charging station market.\nIt’s seven times larger than its nearest competitor, with over 100,000 charging ports and 73% of L2 EV charging stations.\nIts size is especially significant because of network effects.\nOf ChargePoint’s commercial clients, more than 60% of Fortune 500 companies employ ChargePoint charging stations at their corporate offices. If companies such asFacebook(NASDAQ:FB),Netflix(NASDAQ:NFLX),Salesforce(NYSE:CRM),Microsoft(NASDAQ:MSFT) andAdobe(NASDAQ:ADBE) already utilize ChargePoint chargers — which shows other companies who to turn to when they want to install their own EV charging stations — ChargePoint should be able to leverage this array of existing customers to win more and more big-name contracts.\nChargePoint is on its way to dominating the commercial workplace vertical of the EV market for the near- to long-term future.\nFrom a consumer-facing perspective, ChargePoint is also setting itself up for future success.\nThe company hasteamed up with auto makerslike Mercedes-owner Daimler AG(OTCMKTS:DMLRY) andBMW(OTC:BMWYY) tointegrate the locations of its charging stationsinto in-car navigation systems.\nChargePoint also offers a popular app that enables drivers to locate its charging stations, see if they’re currently in-use or not and check prices. The app keeps ChargePoint on consumers’ minds, which will help the company dominate the at-home, residential EV-charging market.\nAgain, it all comes down to ChargePoint’s unmatched network effects.\nWhich is why I believe that, as EVs gradually replace gas cars, ChargePoint has the potential to replace Shell as the leading operator of “refueling” stations.\nNaturally, that would mean huge upside potential for CHPT stock.\nWhich is why CHPT is one of my top picks in EV charging. And long-term, you can bet that CHPT stock will score investors massive returns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163365217,"gmtCreate":1623860001839,"gmtModify":1703821809851,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"How do we ultimately say who \"deserves\" it.","listText":"How do we ultimately say who \"deserves\" it.","text":"How do we ultimately say who \"deserves\" it.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/163365217","repostId":"2143797877","repostType":4,"repost":{"id":"2143797877","pubTimestamp":1623856200,"share":"https://ttm.financial/m/news/2143797877?lang=&edition=fundamental","pubTime":"2021-06-16 23:10","market":"us","language":"en","title":"Why GEO Group Is Soaring 11% This Morning","url":"https://stock-news.laohu8.com/highlight/detail?id=2143797877","media":"Motley Fool","summary":"The private prison operator is the latest meme-stock fave.","content":"<h2>What happened</h2>\n<p>Shares of <b>GEO Group</b> (NYSE:GEO) were running 11% higher in morning trading Wednesday as the Reddit stock trading frenzy latched onto yet another stock that's heavily sold short.</p>\n<h2>So what</h2>\n<p>There was no real news to speak of regarding the private prison operator's business, but with over 35% of its outstanding shares sold short, GEO Group has been adopted as the latest meme stock to get retail investor support.</p>\n<p>While rallying around businesses being \"unfairly\" targeted by hedge funds and other short-sellers is fun, it's no way to invest and sometimes a business deserves the negative opinion held.</p>\n<h2>Now what</h2>\n<p>GEO Group is not in danger of going out of business, at least not anytime soon, but in the very first days of President Joe Biden's new administration, he ordered the Justice Department not to renew its contracts with private prison operators like GEO Group and peer <b>CoreCivic</b>.</p>\n<p>GEO Group's contracts don't begin expiring until 2022, so it has time left before any contracts it has under DOJ purview are killed off (Immigration and Customs Enforcement Homeland Security control are not affected).</p>\n<p>Yet, because GEO Group is structured as a real estate investment trust (REIT), the fact that it suspended its dividend in April to focus on its heavy debt load means the reason most people invest in REITs has been taken away.</p>\n<p>Yes, the business can survive and maybe the divided will be reinstated, but simply piling into a stock based on the number of shares sold short is no way to invest.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why GEO Group Is Soaring 11% This Morning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy GEO Group Is Soaring 11% This Morning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 23:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/16/why-geo-group-is-soaring-11-this-morning/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of GEO Group (NYSE:GEO) were running 11% higher in morning trading Wednesday as the Reddit stock trading frenzy latched onto yet another stock that's heavily sold short.\nSo what\n...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/16/why-geo-group-is-soaring-11-this-morning/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GEO":"GEO惩教集团"},"source_url":"https://www.fool.com/investing/2021/06/16/why-geo-group-is-soaring-11-this-morning/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143797877","content_text":"What happened\nShares of GEO Group (NYSE:GEO) were running 11% higher in morning trading Wednesday as the Reddit stock trading frenzy latched onto yet another stock that's heavily sold short.\nSo what\nThere was no real news to speak of regarding the private prison operator's business, but with over 35% of its outstanding shares sold short, GEO Group has been adopted as the latest meme stock to get retail investor support.\nWhile rallying around businesses being \"unfairly\" targeted by hedge funds and other short-sellers is fun, it's no way to invest and sometimes a business deserves the negative opinion held.\nNow what\nGEO Group is not in danger of going out of business, at least not anytime soon, but in the very first days of President Joe Biden's new administration, he ordered the Justice Department not to renew its contracts with private prison operators like GEO Group and peer CoreCivic.\nGEO Group's contracts don't begin expiring until 2022, so it has time left before any contracts it has under DOJ purview are killed off (Immigration and Customs Enforcement Homeland Security control are not affected).\nYet, because GEO Group is structured as a real estate investment trust (REIT), the fact that it suspended its dividend in April to focus on its heavy debt load means the reason most people invest in REITs has been taken away.\nYes, the business can survive and maybe the divided will be reinstated, but simply piling into a stock based on the number of shares sold short is no way to invest.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168393463,"gmtCreate":1623949017552,"gmtModify":1703824521485,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Wow so many comments here","listText":"Wow so many comments here","text":"Wow so many comments here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/168393463","repostId":"2144742672","repostType":4,"repost":{"id":"2144742672","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623943500,"share":"https://ttm.financial/m/news/2144742672?lang=&edition=fundamental","pubTime":"2021-06-17 23:25","market":"us","language":"en","title":"Facebook launches ads globally for Instagram Reels","url":"https://stock-news.laohu8.com/highlight/detail?id=2144742672","media":"Reuters","summary":"June 17 (Reuters) - Facebook Inc is launching ads globally on its TikTok clone Instagram Reels, the ","content":"<p>June 17 (Reuters) - <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc is launching ads globally on its TikTok clone Instagram Reels, the company said on Thursday.</p>\n<p>The social media company, which is aiming to make money from its short-form video feature, began testing Instagram Reels ads in India, Brazil, Germany and Australia in April. The tests ran with brands such as BMW, Louis Vuitton, Netflix and Uber.</p>\n<p>\"We see Reels as a great way for people to discover new content on Instagram, and so ads are a natural fit,\" said Instagram's Chief Operating Officer Justin Osofsky. \"Brands of all sizes can take advantage of this new creative format in an environment where people are already being entertained.\"</p>\n<p>The company said that Reels ads, which will loop and can be up to 30 seconds long, will appear between individual Reels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Facebook launches ads globally for Instagram Reels</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFacebook launches ads globally for Instagram Reels\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-17 23:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 17 (Reuters) - <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc is launching ads globally on its TikTok clone Instagram Reels, the company said on Thursday.</p>\n<p>The social media company, which is aiming to make money from its short-form video feature, began testing Instagram Reels ads in India, Brazil, Germany and Australia in April. The tests ran with brands such as BMW, Louis Vuitton, Netflix and Uber.</p>\n<p>\"We see Reels as a great way for people to discover new content on Instagram, and so ads are a natural fit,\" said Instagram's Chief Operating Officer Justin Osofsky. \"Brands of all sizes can take advantage of this new creative format in an environment where people are already being entertained.\"</p>\n<p>The company said that Reels ads, which will loop and can be up to 30 seconds long, will appear between individual Reels.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03086":"华夏纳指","09086":"华夏纳指-U","QNETCN":"纳斯达克中美互联网老虎指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144742672","content_text":"June 17 (Reuters) - Facebook Inc is launching ads globally on its TikTok clone Instagram Reels, the company said on Thursday.\nThe social media company, which is aiming to make money from its short-form video feature, began testing Instagram Reels ads in India, Brazil, Germany and Australia in April. The tests ran with brands such as BMW, Louis Vuitton, Netflix and Uber.\n\"We see Reels as a great way for people to discover new content on Instagram, and so ads are a natural fit,\" said Instagram's Chief Operating Officer Justin Osofsky. \"Brands of all sizes can take advantage of this new creative format in an environment where people are already being entertained.\"\nThe company said that Reels ads, which will loop and can be up to 30 seconds long, will appear between individual Reels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166642240,"gmtCreate":1624008407380,"gmtModify":1703826430938,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh, maybe business will fold soon","listText":"Uh oh, maybe business will fold soon","text":"Uh oh, maybe business will fold soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166642240","repostId":"1176081814","repostType":4,"repost":{"id":"1176081814","pubTimestamp":1624002595,"share":"https://ttm.financial/m/news/1176081814?lang=&edition=fundamental","pubTime":"2021-06-18 15:49","market":"us","language":"en","title":"AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=1176081814","media":"bloomberg","summary":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery tar","content":"<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.</p>\n<p>Thailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.</p>\n<p>Shipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.</p>\n<p>The situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.</p>\n<p>AstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.</p>\n<p>The Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.</p>\n<p>AstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.</p>\n<p>Seeking Alternatives</p>\n<p>The Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.</p>\n<p>While not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.</p>\n<p>Now, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.</p>\n<p>Thailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.</p>\n<p>The country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson &amp; Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.</p>\n<p>New to Vaccine-making</p>\n<p>AstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.</p>\n<p>But the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.</p>\n<p>“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”</p>\n<p>AstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.</p>\n<p>The company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.</p>\n<p>It’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.</p>\n<p>In February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.</p>\n<p>Royal Links</p>\n<p>Complicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.</p>\n<p>In January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.</p>\n<p>When former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.</p>\n<p>Prime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.</p>\n<p>One Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.</p>\n<p>“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia><strong>bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-18/astrazeneca-vaccine-faces-more-supply-hurdles-now-from-thailand?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176081814","content_text":"AstraZeneca Plc’s Covid-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.\nThailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only about 3.5 million of those shots this month. Pledging to still give out 6 million doses as planned, officials appear to be making up the shortfall with millions of shots from China’sSinovac Biotech Ltd.\nShipments of shots made by Siam Bioscience -- AstraZeneca’s Bangkok-based partner, which has links to the Thai royal family -- to Malaysia and the Philippines have also been delayed, though both countries say they don’t expect to be waiting for too long.\nThe situation comes on top of delivery problems at India’sSerum Institute of India Ltd., another AstraZeneca partner, which has left developing countries from Nepal to Rwanda short of shots that were promised through the World Health Organization-backed Covax program. Siam Bioscience is AstraZeneca’s sole Covid vaccine partner in Southeast Asia, a region that is trailing on inoculation and where the virus continues to flare, including in Thailand where infections have surged over the past two months.\nAstraZeneca declined to comment, while Siam BioScience didn’t respond to requests for comment.\nThe Philippines now expects a batch of nearly 1.2 million AstraZeneca shots to be shipped from Thailand in mid-July rather than this month, though a government official saidthe initial delaywill not derail the country’s vaccination push. In Malaysia, authorities say they’re working to resolve the issues around the delivery schedule, which the government stated in May would see 610,000 doses arrive from Thailand in June and another 410,000 in July.\nAstraZeneca itself is also facing legal action from the European Union for a production shortfall, with the company only delivering 30 million doses to the bloc in the first quarter, compared with an original target of 120 million.\nSeeking Alternatives\nThe Anglo-Swedish company, which partnered with the University of Oxford on the vaccine, received orders to supply as many as 3 billion doses worldwide before efficacy data came out last year, more than twice as many as any other first wave shot, data compiled by Bloomberg shows.\nWhile not exclusive to AstraZeneca, the various delays -- particularly out of India, which has banned the export of Covid vaccines -- have left dozens of countries that were counting on the shot desperate to find doses elsewhere, and undermined the company’s bid to supply the developing world.\nNow, countries are turning to alternatives, particularly shots developed by Chinese companies Sinovac and Sinopharm that recently received approval from the WHO. While they’re less effective than the Messenger RNA vaccines made by Pfizer Inc., BioNTech SE and Moderna Inc., these shots are easier to store and transport.\nThailand, which aims to vaccinate70% of its populationby the end of this year, is also now allowing regional health authorities to extend the interval between Astrazeneca vaccine doses to 16 weeks, from 10 to 12 weeks previously, though officials say the move is to optimize the shot’s effectiveness and not for lack of supply.\nThe country has alsoordered20 million doses of the Pfizer-BioNTech vaccine and isin talksfor 5 million doses of the single-shot Johnson & Johnson vaccine as it continues to expect deliveries of the Astra shots from Siam Bioscience.\nNew to Vaccine-making\nAstraZeneca’s vaccine is among the cheapest of the first round of Covid shots because the company said it wouldn’t take a profit, selling it at cost.\nBut the lack of economic incentives could have constrained AstraZeneca and its manufacturing partners’ ability to get the supply chain in order, said Carlos Cordon, a professor of strategy and supply chain management at the Institute for Management Development in Lausanne, Switzerland.\n“The supply chain of the Astra vaccine is not an easy one and, logically, one would assume that there will be more than one source of supply to avoid bottlenecks,” Cordon said. “A little bit of an economic incentive would have certainly helped to make companies in the supply chain even eager to make higher production volumes.”\nAstraZeneca’s choice of Thai partner raised questions from the start. Unlike India’s Serum -- which was the world’s biggest vaccine maker before the pandemic -- and other Asia partners like South Korea’sSK Bioscience Co., Siam Bioscience is new to the vaccine-making business.\nThe company was founded in 2009 as Thailand’s first domestic bio-pharmaceutical drugmaker by the father of the nation’s current King Maha Vajiralongkorn, to provide cheaper alternatives to imported drugs. It has also made Covid test kits.\nIt’s set up by theCrown Property Bureau, an agency that managed assets for the palace no matter who sat on the throne. The company had been operating at a loss in the four years leadingup tothe year of pandemic, when it brought in anet profitof 35.8 million baht ($1.1 million), according to data published by the Department of Business Development.\nIn February, Thai Prime Minister Prayuth Chan-Ocha said Siam Bioscience does not seek to profit from making the Astra vaccines.\nRoyal Links\nComplicating matters is Thailand’s lese majeste law, which can see jail time ofup to15 years for defaming the royal family. Its sweeping mandate means that little is said publicly about Siam Bioscience, even as concerns over vaccine supplies grow.\nIn January, Thai officialssaidthat Siam Bioscience would make 200 million doses each year. They haven’t spoken publicly again about the company in detail since.\nWhen former prime-ministerial candidate Thanathorn Juangroongruangkit suggested that Siam Bioscience’s royal ties played a role in its appointment as AstraZeneca’s partner, the high-profile government critic waschargedwith royal defamation.\nPrime Minister Prayuthapologizedthis week to the public for the delay, blaming “supply and distribution issues” without elaborating. Neither the Thai government nor Siam Bioscience responded to repeated requests for information on what is causing the supply shortfalls.\nOne Thaihealthcareindustry veteran, who asked not to be identified for fear of legal repercussions, likened the situation with Siam Bioscience to a bakery that just started making bread.\n“They still haven’t perfected their craft,” he said. “None of us really knows their production capacity because they haven’t publicized it and we can’t criticize it. No one is willing to say. They can’t say it, because it’s Siam Bioscience.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648341,"gmtCreate":1624008259483,"gmtModify":1703826427179,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Wow who would've guessed","listText":"Wow who would've guessed","text":"Wow who would've guessed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648341","repostId":"1113093847","repostType":4,"repost":{"id":"1113093847","pubTimestamp":1624001134,"share":"https://ttm.financial/m/news/1113093847?lang=&edition=fundamental","pubTime":"2021-06-18 15:25","market":"sg","language":"en","title":"Singapore slows the pace of reopening as Covid cases haven't declined significantly","url":"https://stock-news.laohu8.com/highlight/detail?id=1113093847","media":"cnbc","summary":"SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next ","content":"<div>\n<p>SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore slows the pace of reopening as Covid cases haven't declined significantly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore slows the pace of reopening as Covid cases haven't declined significantly\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.cnbc.com/2021/06/18/covid-singapore-slows-pace-of-reopening-as-local-cases-stabilize.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1113093847","content_text":"SINGAPORE — Singapore's government said Friday it will further ease Covid-related restrictions next week, but at a slower pace than previously announced as local infections have not declined significantly.\nThe government startedrelaxing some measuresthis week, including increasing the limits on social gatherings and event attendees.\nIt said that starting Monday, \"higher-risk activities\" such as dining in and indoor mask-off sports and exercises will be allowed to resume in groups of two people — instead of five people as previously announced.\nBarring another super-spreader event or a big cluster of infections, the government will allow those activities for groups of up to five around mid-July.\nSingapore has to be cautious in resuming activities deemed to be of higher risks due to the more transmissible delta variant first detected in India, Health Minister Ong Ye Kung told reporters at a briefing.\nOng said that with a phased reopening, \"we buy time to get more people vaccinated, so the imperative now is to boost vaccinations.\"\nSingapore hasone of the fastest vaccination roll-outsin Asia-Pacific. Around 2.7 million people — or roughly 47% of the population — have received at least the first dose of Covid vaccine as of Monday,latest data by the health ministryshowed.\nThe country had largely controlled the spread of Covid until a flare-up in locally transmitted cases in end-April.Many of the recent cases were caused by the delta variant. The rise in cases forced the government totighten social-distancing measurestwice last month.\nDaily reported casesin the local community fell to single-digit levels for most of last week, but have stayed above 10 cases per day since Sunday as a major cluster of infections emerged around a wet market in southern Singapore.\nOverall, the Southeast Asian country has reported 34 deaths and more than 62,300 confirmed cases since the beginning of 2020 as of Thursday, health ministry data showed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330740,"gmtCreate":1623949416480,"gmtModify":1703824533510,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Great job","listText":"Great job","text":"Great job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330740","repostId":"2144749073","repostType":4,"repost":{"id":"2144749073","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623938100,"share":"https://ttm.financial/m/news/2144749073?lang=&edition=fundamental","pubTime":"2021-06-17 21:55","market":"us","language":"en","title":"Google's cloud taps AMD for new service as chip wars heat up","url":"https://stock-news.laohu8.com/highlight/detail?id=2144749073","media":"Reuters","summary":"June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Goog","content":"<p>June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on <a href=\"https://laohu8.com/S/AMD\">AMD</a>'s newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .</p>\n<p>Cloud computing providers such as Google, Amazon.com Inc&nbsp;and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.</p>\n<p>Google said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as <a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a> and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc&nbsp;are testing the new AMD-based services.</p>\n<p>AMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.</p>\n<p>Intel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google's cloud taps AMD for new service as chip wars heat up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle's cloud taps AMD for new service as chip wars heat up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-17 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on <a href=\"https://laohu8.com/S/AMD\">AMD</a>'s newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .</p>\n<p>Cloud computing providers such as Google, Amazon.com Inc&nbsp;and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.</p>\n<p>Google said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as <a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a> and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc&nbsp;are testing the new AMD-based services.</p>\n<p>AMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.</p>\n<p>Intel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","GOOGL":"谷歌A","SNAP":"Snap Inc","INTC":"英特尔","AMZN":"亚马逊","AMD":"美国超微公司","TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144749073","content_text":"June 17 (Reuters) - Advanced Micro Devices Inc and Alphabet Inc's Google Cloud on Thursday said Google will offer cloud computing services based on AMD's newest data center chip, a move likely to intensify AMD's push to grab market share from rival Intel Corp .\nCloud computing providers such as Google, Amazon.com Inc and Microsoft Corp are some of the biggest buyers of data center chips. They build services on top of the chips to rent the computing power out to millions of customers.\nGoogle said on Thursday it will start offering services based on AMD's \"Milan\" server chip, which AMD released in March. Google said customers such as Snap Inc and Twitter Inc are testing the new AMD-based services.\nAMD has been gaining market share against Intel, which was long the dominant player in data center chips but whose offerings have inferior performance on some measures because of years of stumbles in Intel's manufacturing operations.\nIntel in April announced its \"Ice Lake\" chip competitor to AMD's \"Milan\" chip and said all major cloud providers would support it, but Intel has not said when Google will start offering services based on its latest chip.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169876081,"gmtCreate":1623830661943,"gmtModify":1703820748159,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169876081","repostId":"1182315358","repostType":4,"repost":{"id":"1182315358","pubTimestamp":1623814338,"share":"https://ttm.financial/m/news/1182315358?lang=&edition=fundamental","pubTime":"2021-06-16 11:32","market":"us","language":"en","title":"It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1182315358","media":"MarketWatch","summary":"If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn","content":"<p>If you’re an investor, you need to be flexible, neither a bull nor a bear.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/724d1ea0bb18bddb367c79abf08c1af9\" tg-width=\"1260\" tg-height=\"841\"><span>It takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)</span></p>\n<p>I don’t know when what I call the Blow-Off Top of the Bubble-Blowing Bull Market will end.</p>\n<p>After 12 years being long and strong and having diamond hands without even knowing that term existed, maybe I’m wrong to turn more cautious.</p>\n<p>Maybe the economy will reopen and rejuvenate the country in such a strong manner that corporate earnings in 2022 and 2023 will make today’s prices seem like bargains.</p>\n<p>But I simply don’t think that’s the most likely outcome.</p>\n<p>And if I’m right that we’re in the throes of the Blow-Off Top of the Bubble-Blowing Bull Market, I do not want to be overly long and on the wrong side of the great unwind when it does start.</p>\n<p>I’m not calling for a near-term crash. I am saying that it’s likely going to be hard for the bulls to make as much money this year as they did last year.</p>\n<p>Trading and investing are tough. There’s always someone on the other side of every trade you make. Always think about who that is and why they are willing to take the other side of your transaction. When you buy, why are they selling it to you at that price? When you sell, who is buying it from you and what are their motivations? Remember, I’ve talked before about how&nbsp;good analysis starts with empathy.</p>\n<p><b>If I’m selling, who’s buying — and why?</b></p>\n<p>So let’s answer this question right now. Who is buying stocks and cryptos from me when I’ve trimmed and sold for the past month or so? Sure, there are banks and institutions and hedge funds and family offices investing and trading, just as always. On the other hand, remember two years ago when I got back from a hedge fund investment conference&nbsp;in Abu Dhabi and everybody was desperate for returns:</p>\n<p>Amid low interest rates and other investors’ focus on options, credit and currencies, “the lack of focus on traditional stocks and funds that invest in publicly traded stocks makes me think that there is probably more opportunity in such assets than people realize. I certainly see some very compelling long ideas in Revolutionary companies like WORK and TWTR and TSLA.”</p>\n<p>Since that post, back a year and a half ago, Slack&nbsp;went from $21 to being bought out at $45, Twitter&nbsp;went from $27 to $61, and Tesla&nbsp;went from $81 to $616. And funds that were looking everywhere but in the stock market for big gains are … well, pretty much in the markets now and long a bunch of stocks and even long a few cryptos.</p>\n<p>And now that those stocks and cryptos and most other assets have gone parabolic in the past year — coming on top of the 10-year bull market — the billion-dollar fund managers are joined by&nbsp;23-year-old TikTok influencers&nbsp;doing bitcoin&nbsp;trading astrology.</p>\n<p>Yes, for real, and she’s very popular. She’s even been right about some of bitcoin’s action in the past few months! If you’re selling cryptos and fintech stocks right now, you’re selling to her and her followers. And also to my friend’s son, who just graduated from a tiny, rural school and whose unemployed uncle gave him $500 to “buy some cryptos. And make sure you get some fintech. I don’t know the symbol, but just look it up and you’ll do fine over the long run.”&nbsp;Bearish anecdotes everywhere I look, as I wrote recently.</p>\n<p><b>Mr. Market</b></p>\n<p>The other thing to remember about who’s on the other side of your trade is always to remember that there are smart, cutthroat traders and investors who went to the best schools and have access to more research and real-time data and instant trading access to all kinds of derivatives to layer into their bets. And the only thing they do all day, every day, is figure out how to take your money in mostly legal ways. They’re not playing around. They have no sympathy for you, even if they might empathize with you to better understand your motivations to better take your money.</p>\n<p>Mr. Market is mean. He’s not nice. He can be cruel. He can force liquidations that create other liquidations. He can shut off access to capital. He can take down 200-year-old banks in a day. In one day.</p>\n<p>Sometimes the markets lead the economy and not the other way around. Ironically, when we were young, we were taught that the Great Depression started when the stock market crashed on Black Friday in 1929. But then when we get older, we were taught that it wasn’t actually the crash that created the Great Depression, rather the economy was already crashing and the stock market just didn’t realize it as it continued on its merry way toward a terrible Blow-Off Top of a nine-year Bubble-Blowing Bull Market that culminated with the Dow Jones Industrial Average&nbsp;up 400% from the 1921 lows to the 1929 highs.</p>\n<p><img src=\"https://static.tigerbbs.com/3a6516337aacc614d83584ea90e174f2\" tg-width=\"1260\" tg-height=\"870\"></p>\n<p><b>Learning from Soros</b></p>\n<p>But looking back, it’s clear that both theories are equally right and wrong — the market crashed because the economy wasn’t as good as the market thought it was,<i>and</i>the economy crashed because the markets shut down access to capital for investment and growth.</p>\n<p>It was “reflexive,” to borrow a term from the great hedge fund manager&nbsp;George Soros.</p>\n<p>He wrote, and the concept is important to understand:</p>\n<p>“I continued to consider myself a failed philosopher. All this changed as a result of the financial crisis of 2008. My conceptual framework enabled me both to anticipate the crisis and to deal with it when it finally struck…</p>\n<p>“I can state the core idea in two relatively simple propositions. One is that in situations that have thinking participants, the participants’ view of the world is always partial and distorted. That is the principle of fallibility. The other is that these distorted views can influence the situation to which they relate because false views lead to inappropriate actions. That is the principle of reflexivity…</p>\n<p>“Recognizing reflexivity has been sacrificed to the vain pursuit of certainty in human affairs, most notably in economics, and yet, uncertainty is the key feature of human affairs. Economic theory is built on the concept of equilibrium, and that concept is in direct contradiction with the concept of reflexivity…</p>\n<p>“A positive feedback process is self-reinforcing. It cannot go on forever because eventually the participants’ views would become so far removed from objective reality that the participants would have to recognize them as unrealistic. Nor can the iterative process occur without any change in the actual state of affairs, because it is in the nature of positive feedback that it reinforces whatever tendency prevails in the real world. Instead of equilibrium, we are faced with a dynamic disequilibrium or what may be described as far-from-equilibrium conditions. Usually in far-from-equilibrium situations the divergence between perceptions and reality leads to a climax which sets in motion a positive feedback process in the opposite direction. Such initially self-reinforcing but eventually self-defeating boom-bust processes or bubbles are characteristic of financial markets, but they can also be found in other spheres. There, I call them fertile fallacies—interpretations of reality that are distorted, yet produce results which reinforce the distortion.”</p>\n<p>Stay flexible</p>\n<p>Far-from-equilibrium conditions was what we had in 2010-2013 when we loaded up on Revolutionary stocks and started buying cryptos like bitcoin. Far-from-equilibrium conditions might be what we have in front of us right now when I suggest getting cautious instead.</p>\n<p>We don’t want to be permabulls. (You for sure don’t want to be a permabear!) We have to be flexible. We have to let our analysis and risk/reward scenarios dictate how much risk we’re taking and when. We have to pay attention to the cycles, the self-reinforcing cycles that drive economies and markets and valuations and earnings and societal interactions and bailouts and financial crises and bubbles and busts and, heaven forbid, just simple stagnation.</p>\n<p>It’s as if everybody forgets that markets can bubble and crash and stagnate. They forget that markets can grind for years on end without making new highs, or without even making higher highs. Do you not remember telling your money manager sometime in 2010-2012 that “If I’d just handled the Great Financial Crisis (and/or the Dot-Com Crash) a little better, I’d be in better shape.” I used to hear people say that to me all the time. I haven’t heard anybody say that lately. Everybody’s having fun in this market … at least for now.</p>\n<p>Most traders will tell you that they are “just trading the market that is in front of them.” Well, I don’t know when the bubble will pop, but I do know that I don’t want to be on the wrong side of this market when it does. And I do know that we won’t know the bubble has really popped until the self-reinforcing reflexive feedback loop has made it painful for the vast majority of people who are right now feeling wealthy, feeling secure, feeling like they’ve got this trading and investing thing all figured out.</p>\n<p>We are all fallible. Be careful while it’s fun. Be bold when it’s painful. That’s how I’ve done it for the last 25 years. We were boldly buying these assets when it was painful for others. I’m careful right now because everybody else is having fun.</p>\n<p>I spend a lot of time looking for new ideas and I won’t let my overall market outlook deter me from buying a new name or two. But I want to remain overall cautious and less aggressive than I have been for most of the last decade.</p>\n<p>As a matter of fact,&nbsp;I might have at least a couple Trade Alerts that I’ll be sending out this week, one long and one short idea. Being flexible, see?</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 11:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)\nI don’t know when what...</p>\n\n<a href=\"https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182315358","content_text":"If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)\nI don’t know when what I call the Blow-Off Top of the Bubble-Blowing Bull Market will end.\nAfter 12 years being long and strong and having diamond hands without even knowing that term existed, maybe I’m wrong to turn more cautious.\nMaybe the economy will reopen and rejuvenate the country in such a strong manner that corporate earnings in 2022 and 2023 will make today’s prices seem like bargains.\nBut I simply don’t think that’s the most likely outcome.\nAnd if I’m right that we’re in the throes of the Blow-Off Top of the Bubble-Blowing Bull Market, I do not want to be overly long and on the wrong side of the great unwind when it does start.\nI’m not calling for a near-term crash. I am saying that it’s likely going to be hard for the bulls to make as much money this year as they did last year.\nTrading and investing are tough. There’s always someone on the other side of every trade you make. Always think about who that is and why they are willing to take the other side of your transaction. When you buy, why are they selling it to you at that price? When you sell, who is buying it from you and what are their motivations? Remember, I’ve talked before about how good analysis starts with empathy.\nIf I’m selling, who’s buying — and why?\nSo let’s answer this question right now. Who is buying stocks and cryptos from me when I’ve trimmed and sold for the past month or so? Sure, there are banks and institutions and hedge funds and family offices investing and trading, just as always. On the other hand, remember two years ago when I got back from a hedge fund investment conference in Abu Dhabi and everybody was desperate for returns:\nAmid low interest rates and other investors’ focus on options, credit and currencies, “the lack of focus on traditional stocks and funds that invest in publicly traded stocks makes me think that there is probably more opportunity in such assets than people realize. I certainly see some very compelling long ideas in Revolutionary companies like WORK and TWTR and TSLA.”\nSince that post, back a year and a half ago, Slack went from $21 to being bought out at $45, Twitter went from $27 to $61, and Tesla went from $81 to $616. And funds that were looking everywhere but in the stock market for big gains are … well, pretty much in the markets now and long a bunch of stocks and even long a few cryptos.\nAnd now that those stocks and cryptos and most other assets have gone parabolic in the past year — coming on top of the 10-year bull market — the billion-dollar fund managers are joined by 23-year-old TikTok influencers doing bitcoin trading astrology.\nYes, for real, and she’s very popular. She’s even been right about some of bitcoin’s action in the past few months! If you’re selling cryptos and fintech stocks right now, you’re selling to her and her followers. And also to my friend’s son, who just graduated from a tiny, rural school and whose unemployed uncle gave him $500 to “buy some cryptos. And make sure you get some fintech. I don’t know the symbol, but just look it up and you’ll do fine over the long run.” Bearish anecdotes everywhere I look, as I wrote recently.\nMr. Market\nThe other thing to remember about who’s on the other side of your trade is always to remember that there are smart, cutthroat traders and investors who went to the best schools and have access to more research and real-time data and instant trading access to all kinds of derivatives to layer into their bets. And the only thing they do all day, every day, is figure out how to take your money in mostly legal ways. They’re not playing around. They have no sympathy for you, even if they might empathize with you to better understand your motivations to better take your money.\nMr. Market is mean. He’s not nice. He can be cruel. He can force liquidations that create other liquidations. He can shut off access to capital. He can take down 200-year-old banks in a day. In one day.\nSometimes the markets lead the economy and not the other way around. Ironically, when we were young, we were taught that the Great Depression started when the stock market crashed on Black Friday in 1929. But then when we get older, we were taught that it wasn’t actually the crash that created the Great Depression, rather the economy was already crashing and the stock market just didn’t realize it as it continued on its merry way toward a terrible Blow-Off Top of a nine-year Bubble-Blowing Bull Market that culminated with the Dow Jones Industrial Average up 400% from the 1921 lows to the 1929 highs.\n\nLearning from Soros\nBut looking back, it’s clear that both theories are equally right and wrong — the market crashed because the economy wasn’t as good as the market thought it was,andthe economy crashed because the markets shut down access to capital for investment and growth.\nIt was “reflexive,” to borrow a term from the great hedge fund manager George Soros.\nHe wrote, and the concept is important to understand:\n“I continued to consider myself a failed philosopher. All this changed as a result of the financial crisis of 2008. My conceptual framework enabled me both to anticipate the crisis and to deal with it when it finally struck…\n“I can state the core idea in two relatively simple propositions. One is that in situations that have thinking participants, the participants’ view of the world is always partial and distorted. That is the principle of fallibility. The other is that these distorted views can influence the situation to which they relate because false views lead to inappropriate actions. That is the principle of reflexivity…\n“Recognizing reflexivity has been sacrificed to the vain pursuit of certainty in human affairs, most notably in economics, and yet, uncertainty is the key feature of human affairs. Economic theory is built on the concept of equilibrium, and that concept is in direct contradiction with the concept of reflexivity…\n“A positive feedback process is self-reinforcing. It cannot go on forever because eventually the participants’ views would become so far removed from objective reality that the participants would have to recognize them as unrealistic. Nor can the iterative process occur without any change in the actual state of affairs, because it is in the nature of positive feedback that it reinforces whatever tendency prevails in the real world. Instead of equilibrium, we are faced with a dynamic disequilibrium or what may be described as far-from-equilibrium conditions. Usually in far-from-equilibrium situations the divergence between perceptions and reality leads to a climax which sets in motion a positive feedback process in the opposite direction. Such initially self-reinforcing but eventually self-defeating boom-bust processes or bubbles are characteristic of financial markets, but they can also be found in other spheres. There, I call them fertile fallacies—interpretations of reality that are distorted, yet produce results which reinforce the distortion.”\nStay flexible\nFar-from-equilibrium conditions was what we had in 2010-2013 when we loaded up on Revolutionary stocks and started buying cryptos like bitcoin. Far-from-equilibrium conditions might be what we have in front of us right now when I suggest getting cautious instead.\nWe don’t want to be permabulls. (You for sure don’t want to be a permabear!) We have to be flexible. We have to let our analysis and risk/reward scenarios dictate how much risk we’re taking and when. We have to pay attention to the cycles, the self-reinforcing cycles that drive economies and markets and valuations and earnings and societal interactions and bailouts and financial crises and bubbles and busts and, heaven forbid, just simple stagnation.\nIt’s as if everybody forgets that markets can bubble and crash and stagnate. They forget that markets can grind for years on end without making new highs, or without even making higher highs. Do you not remember telling your money manager sometime in 2010-2012 that “If I’d just handled the Great Financial Crisis (and/or the Dot-Com Crash) a little better, I’d be in better shape.” I used to hear people say that to me all the time. I haven’t heard anybody say that lately. Everybody’s having fun in this market … at least for now.\nMost traders will tell you that they are “just trading the market that is in front of them.” Well, I don’t know when the bubble will pop, but I do know that I don’t want to be on the wrong side of this market when it does. And I do know that we won’t know the bubble has really popped until the self-reinforcing reflexive feedback loop has made it painful for the vast majority of people who are right now feeling wealthy, feeling secure, feeling like they’ve got this trading and investing thing all figured out.\nWe are all fallible. Be careful while it’s fun. Be bold when it’s painful. That’s how I’ve done it for the last 25 years. We were boldly buying these assets when it was painful for others. I’m careful right now because everybody else is having fun.\nI spend a lot of time looking for new ideas and I won’t let my overall market outlook deter me from buying a new name or two. But I want to remain overall cautious and less aggressive than I have been for most of the last decade.\nAs a matter of fact, I might have at least a couple Trade Alerts that I’ll be sending out this week, one long and one short idea. Being flexible, see?","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166646213,"gmtCreate":1624008372332,"gmtModify":1703826429326,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh orphazyme","listText":"Uh oh orphazyme","text":"Uh oh orphazyme","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166646213","isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648869,"gmtCreate":1624008279651,"gmtModify":1703826427502,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Ok here we go","listText":"Ok here we go","text":"Ok here we go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648869","repostId":"2143926717","repostType":2,"repost":{"id":"2143926717","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623854867,"share":"https://ttm.financial/m/news/2143926717?lang=&edition=fundamental","pubTime":"2021-06-16 22:47","market":"us","language":"en","title":"At Home Group accepts Hellman & Friedman's raised offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2143926717","media":"Reuters","summary":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equ","content":"<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>At Home Group accepts Hellman & Friedman's raised offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAt Home Group accepts Hellman & Friedman's raised offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOME":"At Home Group Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143926717","content_text":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman & Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.\nPlano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.\nHonest Capital said in May, in a letter to At Home, the initial offer from Hellman & Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.\nAt Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.\n\"This price increase represents our best and final offer,\" Hellman & Friedman Partner Erik Ragatz said in a statement on Wednesday.\nH&F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.\nHonest Capital could not be immediately reached for a comment, and CAS did not immediately respond.","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641940,"gmtCreate":1624008161080,"gmtModify":1703826425716,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"They will always win","listText":"They will always win","text":"They will always win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166641940","repostId":"2144861727","repostType":2,"repost":{"id":"2144861727","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624001354,"share":"https://ttm.financial/m/news/2144861727?lang=&edition=fundamental","pubTime":"2021-06-18 15:29","market":"hk","language":"en","title":"HK police charges two Apple Daily execs with collusion with foreign country","url":"https://stock-news.laohu8.com/highlight/detail?id=2144861727","media":"Reuters","summary":"HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executi","content":"<html><body><p>HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.</p><p>   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung.</p><p> (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)</p><p>((marius.zaharia@thomsonreuters.com; +852 2843 6358;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK police charges two Apple Daily execs with collusion with foreign country</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK police charges two Apple Daily execs with collusion with foreign country\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 15:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.</p><p>   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung.</p><p> (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)</p><p>((marius.zaharia@thomsonreuters.com; +852 2843 6358;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"03086":"华夏纳指","09086":"华夏纳指-U","AAPL":"苹果"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144861727","content_text":"HONG KONG, June 18 (Reuters) - Hong Kong police charged on Friday the chief editor and chief executive of pro-democracy tabloid Apple Daily with collusion with a foreign country to endanger national security.   Police said in a statement they had charged two males aged 47 and 59, who they did not name, and that the two would be brought to West Kowloon Magistrates' Court on Saturday. Apple Daily reported the two charged were editor-in-chief Ryan Law and chief executive officer Cheung Kim-hung. (Reporting by Twinnie Siu; Writing by Marius Zaharia; Editing by Alex Richardson)((marius.zaharia@thomsonreuters.com; +852 2843 6358;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168358986,"gmtCreate":1623953223445,"gmtModify":1703824605541,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Post here","listText":"Post here","text":"Post here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168358986","isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351480,"gmtCreate":1623953188340,"gmtModify":1703824605213,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Apple try harder","listText":"Apple try harder","text":"Apple try harder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351480","repostId":"1139981231","repostType":2,"repost":{"id":"1139981231","pubTimestamp":1623910261,"share":"https://ttm.financial/m/news/1139981231?lang=&edition=fundamental","pubTime":"2021-06-17 14:11","market":"us","language":"en","title":"Apple Struggles in Push to Make Healthcare Its Greatest Legacy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139981231","media":"The Wall Street Journal","summary":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leade","content":"<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cdcc89ff3fd1e1d8ec3f02f3aaf52457\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Under the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.</span></p>\n<p>Apple&nbsp;Inc.&nbsp;Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.</p>\n<p>Apple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.</p>\n<p>Today those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.</p>\n<p>The new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.</p>\n<p>An Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as&nbsp;heart-rate notifications&nbsp;in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.</p>\n<p>“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.</p>\n<p>Looking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com&nbsp;Inc.’s&nbsp;high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch&nbsp;virtual care across 50 states.</p>\n<p>Under Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.</p>\n<p>Apple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.</p>\n<p>One of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.</p>\n<p>Apple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/837161c8fc0a7b93c5c67936fe293453\" tg-width=\"1260\" tg-height=\"840\"><span>Apple Chief Operating Officer Jeff Williams oversees its health unit.</span></p>\n<p>The team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.</p>\n<p>If Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.</p>\n<p>To start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.</p>\n<p>The effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.</p>\n<p>Dr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.</p>\n<p>Those issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.</p>\n<p>Apple’s spokesman said such criticisms are inaccurate.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/01a35a283d15f6de16455cae846a617b\" tg-width=\"1260\" tg-height=\"840\"><span>Dr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.</span></p>\n<p>Employees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.</p>\n<p>Apple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.</p>\n<p>The spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.</p>\n<p>Mr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.</p>\n<p>In addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.</p>\n<p>A recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.</p>\n<p>HealthHabit&nbsp;offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.</p>\n<p>Half the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.</p>\n<p>Data supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.</p>\n<p>During a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.</p>\n<p>In the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.</p>\n<p>Rival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.</p>\n<p>The Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Struggles in Push to Make Healthcare Its Greatest Legacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Struggles in Push to Make Healthcare Its Greatest Legacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 ...</p>\n\n<a href=\"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139981231","content_text":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.\nApple Inc. Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.\nApple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.\nToday those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.\nThe new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.\nAn Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as heart-rate notifications in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.\n“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.\nLooking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com Inc.’s high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch virtual care across 50 states.\nUnder Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.\nApple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.\nOne of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.\nApple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.\nApple Chief Operating Officer Jeff Williams oversees its health unit.\nThe team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.\nIf Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.\nTo start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.\nThe effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.\nDr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.\nThose issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.\nApple’s spokesman said such criticisms are inaccurate.\nDr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.\nEmployees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.\nApple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.\nThe spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.\nMr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.\nIn addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.\nA recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.\nHealthHabit offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.\nHalf the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.\nData supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.\nDuring a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.\nIn the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.\nRival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.\nThe Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.","news_type":1},"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351110,"gmtCreate":1623953150130,"gmtModify":1703824604234,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"China big brother","listText":"China big brother","text":"China big brother","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351110","repostId":"2144714222","repostType":2,"repost":{"id":"2144714222","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623907357,"share":"https://ttm.financial/m/news/2144714222?lang=&edition=fundamental","pubTime":"2021-06-17 13:22","market":"sh","language":"en","title":"China's liaison office in Hong Kong backs 'just action' on Apple Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2144714222","media":"Reuters","summary":"BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported w","content":"<html><body><p>BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.</p><p>   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement.</p><p> (Reporting by Tony Munroe; Editing by Clarence Fernandez)</p><p>((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's liaison office in Hong Kong backs 'just action' on Apple Daily</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's liaison office in Hong Kong backs 'just action' on Apple Daily\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-17 13:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.</p><p>   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement.</p><p> (Reporting by Tony Munroe; Editing by Clarence Fernandez)</p><p>((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","09086":"华夏纳指-U","03086":"华夏纳指"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144714222","content_text":"BEIJING, June 17 (Reuters) - China's Hong Kong Liaison Office said on Thursday it firmly supported what it described as the \"just action\" of the city's police, who arrested five executives of the Apple Daily newspaper under a new national security law.   \"No matter what kind of professional identity and background he has, no matter what kind of forces he is backed by, anyone who violates the Hong Kong National Security Law and other relevant laws will be severely punished,\" the Liaison Office said in a statement. (Reporting by Tony Munroe; Editing by Clarence Fernandez)((tony.munroe@thomsonreuters.com; +86 10 6627 1288; Reuters Messaging: tony.munroe.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168353403,"gmtCreate":1623953097902,"gmtModify":1703824603748,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Buy the dip!","listText":"Buy the dip!","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168353403","repostId":"2144405557","repostType":2,"repost":{"id":"2144405557","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623952545,"share":"https://ttm.financial/m/news/2144405557?lang=&edition=fundamental","pubTime":"2021-06-18 01:55","market":"us","language":"en","title":"US STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2144405557","media":"Reuters","summary":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news","content":"<html><body><p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p><p>   * New jobless claims up last week</p><p>   * CureVac tumbles on missing COVID-19 vaccine efficacy goal</p><p>   * Indexes: Dow down 0.5%, S&amp;P up 0.1%, Nasdaq gains 1%</p><p> (Adds details, updates prices)</p><p>   By Medha Singh and David French</p><p>   June 17 (Reuters) - The Nasdaq jumped on Thursday, at <a href=\"https://laohu8.com/S/AONE\">one</a> point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.</p><p>   The performance of the tech-heavy Nasdaq was in stark contrast to the S&amp;P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.</p><p>   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.</p><p>   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.</p><p>   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.  </p><p>   Still, shares of Apple Inc   , Microsoft Corp</p><p> , Amazon.com Inc    and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.</p><p>   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.</p><p>   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"</p><p>   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.</p><p>   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&amp;P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite</p><p>  added 127.04 points, or 0.9%, to 14,166.73.</p><p>   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.   </p><p>   The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&amp;P sectors.   </p><p>   Other economically sensitive stocks including materials</p><p>  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.  </p><p>   \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.</p><p>   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.  </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)</p><p>((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Tech-heavy Nasdaq ignores hawkish Fed news to advance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 01:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p><p>   * New jobless claims up last week</p><p>   * CureVac tumbles on missing COVID-19 vaccine efficacy goal</p><p>   * Indexes: Dow down 0.5%, S&amp;P up 0.1%, Nasdaq gains 1%</p><p> (Adds details, updates prices)</p><p>   By Medha Singh and David French</p><p>   June 17 (Reuters) - The Nasdaq jumped on Thursday, at <a href=\"https://laohu8.com/S/AONE\">one</a> point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.</p><p>   The performance of the tech-heavy Nasdaq was in stark contrast to the S&amp;P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.</p><p>   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.</p><p>   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.</p><p>   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.  </p><p>   Still, shares of Apple Inc   , Microsoft Corp</p><p> , Amazon.com Inc    and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.</p><p>   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.</p><p>   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"</p><p>   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.</p><p>   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&amp;P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite</p><p>  added 127.04 points, or 0.9%, to 14,166.73.</p><p>   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.   </p><p>   The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&amp;P sectors.   </p><p>   Other economically sensitive stocks including materials</p><p>  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.  </p><p>   \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.</p><p>   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.  </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)</p><p>((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SCHW":"嘉信理财","NDAQ":"纳斯达克OMX交易所"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144405557","content_text":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)   * New jobless claims up last week   * CureVac tumbles on missing COVID-19 vaccine efficacy goal   * Indexes: Dow down 0.5%, S&P up 0.1%, Nasdaq gains 1% (Adds details, updates prices)   By Medha Singh and David French   June 17 (Reuters) - The Nasdaq jumped on Thursday, at one point approaching its lifetime intraday high set in April, as U.S. technology stocks gained on optimism around a speedy economic recovery.   The performance of the tech-heavy Nasdaq was in stark contrast to the S&P 500 and Dow, which slumped as investors reacted negatively to the Federal Reserve's unexpectedly hawkish message on monetary policy on Wednesday.   Chipmaker Nvidia Corp    jumped 5.4%, leading the charge among technology behemoths after Jefferies raised its price target on the stock.   Technology shares, which generally perform better when interest rates are low, powered a rally on Wall Street last year as investors flocked to stocks seen as relatively safe during times of economic turmoil.   The group has come under pressure this year on fears that rising inflation would lead the Fed to hike interest rates sooner than expected. The central bank on Wednesday moved its first projected rate increases from 2024 into 2023.     Still, shares of Apple Inc   , Microsoft Corp , Amazon.com Inc    and Facebook Inc    reversed premarket declines to rise between 1.4% and 2% as investors bet that a steady economic rebound would boost demand for their products in the long run.   \"Yes there is rising inflation but the market is focusing more on the positives of improving earnings, robust GDP growth and the wider economy getting stronger,\" said Randy Frederick, vice president of trading and derivatives at Charles Schwab in Austin, Texas.   \"Today's action is indicative that the Fed hasn't said anything that the market didn't already know.\"   The Nasdaq briefly advanced to within 16 points of its lifetime peak achieved on April 29, before pulling back a touch.   By 1:55PM ET, the Dow Jones Industrial Average    fell 198.57 points, or 0.58%, to 33,835.1, the S&P 500    gained 0.24 points, or 0.01%, to 4,223.94 and the Nasdaq Composite  added 127.04 points, or 0.9%, to 14,166.73.   Interest rate-sensitive bank stocks    slumped -3.8% as longer dated U.S. Treasury yields dropped.      The strengthening dollar, another by-product of the previous day's Fed news, pushed U.S. oil prices down from the multi-year high hit earlier in the week. The energy index   , in turn, fell more than 3%, the biggest laggard among the 11 main S&P sectors.      Other economically sensitive stocks including materials  and industrials    fell 2.4% and 1.5% respectively, as data showed jobless claims rising last week for the first time in more than a month. Still, layoffs appeared to be easing amid a reopening economy and a shortage of people willing to work.     \"In the balance of June and into the summer we anticipate continued volatility as we get more signals from economic data, Fed policy and as we get into the earnings season,\" said Greg Bassuk, chief executive officer at AXS Investments in New York.   In corporate news, U.S.-listed shares of CureVac NV    sank 41.5% after the German biotech said its COVID-19 vaccine was 47% effective in a late-stage trial, missing the study's main goal.      <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ U.S. tech stocks vulnerable to changes in interest rates       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Shashank Nayar and Medha Singh in Bengaluru; Editing by Sriraj Kalluvila, Anil D'Silva, Maju Samuel and Dan Grebler)((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168339605,"gmtCreate":1623949448907,"gmtModify":1703824534994,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"A lot of potential","listText":"A lot of potential","text":"A lot of potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168339605","repostId":"1175322624","repostType":4,"repost":{"id":"1175322624","pubTimestamp":1623940991,"share":"https://ttm.financial/m/news/1175322624?lang=&edition=fundamental","pubTime":"2021-06-17 22:43","market":"us","language":"en","title":"Fisker Jumps on EV-Production Pact With Magna International","url":"https://stock-news.laohu8.com/highlight/detail?id=1175322624","media":".thestreet","summary":"Fisker   was higher after it said it signed an agreement under which Magna International,  the mobility technology company, would produce its electric vehicles.As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik F","content":"<p>Fisker&nbsp;(<b>FSR</b>) &nbsp;was higher after it&nbsp;said&nbsp;it signed an agreement under which Magna International,&nbsp;(<b>MGA</b>)&nbsp;the mobility technology company, would produce its electric vehicles.</p>\n<p>As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.</p>\n<p>\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.</p>\n<p>The Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.</p>\n<p>The agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.</p>\n<p>The Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.</p>\n<p>Fisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below&nbsp;€32,000 ($38,200) in Germany (including taxes and EV-related subsidies).</p>\n<p>\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.</p>\n<p>Fisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fisker Jumps on EV-Production Pact With Magna International</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFisker Jumps on EV-Production Pact With Magna International\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement><strong>.thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, ...</p>\n\n<a href=\"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSR":"菲斯克"},"source_url":"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175322624","content_text":"Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\n\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.\nThe Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.\nThe agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.\nThe Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.\nFisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below €32,000 ($38,200) in Germany (including taxes and EV-related subsidies).\n\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.\nFisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330994,"gmtCreate":1623949381818,"gmtModify":1703824532366,"author":{"id":"3582871469502818","authorId":"3582871469502818","authorIdStr":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582871469502818"},"themes":[],"htmlText":"Yeah right","listText":"Yeah right","text":"Yeah right","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330994","repostId":"2144744636","repostType":4,"repost":{"id":"2144744636","pubTimestamp":1623940250,"share":"https://ttm.financial/m/news/2144744636?lang=&edition=fundamental","pubTime":"2021-06-17 22:30","market":"us","language":"en","title":"Low dosage may be behind low efficacy of CureVac vaccine: Study leader","url":"https://stock-news.laohu8.com/highlight/detail?id=2144744636","media":"The Straits Times","summary":"BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disa","content":"<div>\n<p>BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Low dosage may be behind low efficacy of CureVac vaccine: Study leader</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLow dosage may be behind low efficacy of CureVac vaccine: Study leader\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVAC":"CureVac B.V."},"source_url":"http://www.straitstimes.com/world/europe/low-dosage-may-be-behind-low-efficacy-of-curevac-vaccine-study-leader","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144744636","content_text":"BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said on Thursday (June 17).\nThe German biotech's vaccine proved only 47 per cent effective in an initial trial, far lower than those of rivals BioNTech/Pfizer and Moderna, which are also based on mRNA technology and had efficacy rates well above 90 per cent.\nDr Peter Kremsner from the University Hospital in Tuebingen which is running the trial, told Reuters the low efficacy is \"very likely due to the dose\".\nUnlike BioNTech and Moderna, CureVac did not modify the mRNA used in the shots and therefore a higher dosage was not possible because of the side effects to be expected, Dr Kremsner said.\nWith just 12 micrograms of mRNA per dose, the company has been seeking to position itself as a low-dose alternative to BioNTech and Moderna's established shots with 30 and 100 micrograms per shot, respectively.\nIt is also easy to store and cheaper than the other mRNA shots too.\nThe European Union has agreed to pay 12 euros (S$19.20) per dose for supplies of the shot, an EU internal document shows, but has paid more than 15 euros for the other mRNA shots.\nHowever, the interim trial analysis goes some way to challenging the expectation, which was previously reflected in the company's share price, that all mRNA vaccines are similar.\nThe news wiped as much as 52 per cent off the company's value on Thursday.\nCureVac said on Wednesday that new variants had proved a headwind, but data from BioNTech and Moderna have, however, so far suggested only somewhat weaker protection against new variants.\nDr Kremsner said he thought it was probably a \"long shot\" as to whether CureVac's vaccine might turn out to be more effective when targeting a particular variant.\nThe disappointing results are a blow since European governments had been hoping to add it to their arsenal after age limits were imposed on the use of the Johnson & Johnson and AstraZeneca vaccines due to a link to extremely rare but potentially fatal clotting disorders.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}